<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Rapid diagnostic tests for plague - Jullien, S - 2020 | Cochrane Library</title> <meta content="Rapid diagnostic tests for plague - Jullien, S - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013459.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Rapid diagnostic tests for plague - Jullien, S - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013459.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013459.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Rapid diagnostic tests for plague" name="citation_title"/> <meta content="Sophie Jullien" name="citation_author"/> <meta content="Barcelona Institute for Global Health, University of Barcelona" name="citation_author_institution"/> <meta content="sophjullien@gmail.com" name="citation_author_email"/> <meta content="Harsha A Dissanayake" name="citation_author"/> <meta content="National Hospital of Sri Lanka" name="citation_author_institution"/> <meta content="Marty Chaplin" name="citation_author"/> <meta content="Liverpool School of Tropical Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD013459.pub2" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/06/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013459.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013459.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013459.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antigens, Bacterial [*analysis]; Confidence Intervals; Cross-Sectional Studies; False Negative Reactions; False Positive Reactions; Plague [*diagnosis, immunology]; Sensitivity and Specificity; Time Factors; Yersinia pestis [*immunology]" name="citation_keywords"/> <meta content="" name="citation_fulltext_world_readable"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013459.pub2&amp;doi=10.1002/14651858.CD013459.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WcPhDegp";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013459\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013459\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ko","ms","ja","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013459.pub2",title:"Rapid diagnostic tests for plague",firstPublishedDate:"Jun 26, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Infectious Diseases Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013459.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013459.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013459.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013459.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013459.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013459.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013459.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013459.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013459.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013459.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2739 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013459.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0017"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0019"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-sec-0062"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/appendices#CD013459-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/table_n/CD013459StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/table_n/CD013459StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Authors. Cochrane Database of Systematic Reviews published by John Wiley &amp; Sons, Ltd. on behalf of The Cochrane Collaboration." data-creative-commons="true" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Rapid diagnostic tests for plague</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information#CD013459-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Sophie Jullien</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information#CD013459-cr-0005">Harsha A Dissanayake</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information#CD013459-cr-0006">Marty Chaplin</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information/en#CD013459-sec-0081">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 June 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013459.pub2">https://doi.org/10.1002/14651858.CD013459.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013459-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013459-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013459-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013459-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013459-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013459-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013459-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013459-abs-0001" lang="en"> <section id="CD013459-sec-0001"> <h3 class="title" id="CD013459-sec-0001">Background</h3> <p>Plague is a severe disease associated with high mortality. Late diagnosis leads to advance stage of the disease with worse outcomes and higher risk of spread of the disease. A rapid diagnostic test (RDT) could help in establishing a prompt diagnosis of plague. This would improve patient care and help appropriate public health response. </p> </section> <section id="CD013459-sec-0002"> <h3 class="title" id="CD013459-sec-0002">Objectives</h3> <p>To determine the diagnostic accuracy of the RDT based on the antigen F1 (F1RDT) for detecting plague in people with suspected disease. </p> </section> <section id="CD013459-sec-0003"> <h3 class="title" id="CD013459-sec-0003">Search methods</h3> <p>We searched the CENTRAL, Embase, Science Citation Index, Google Scholar, the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov up to 15 May 2019, and PubMed (MEDLINE) up to 27 August 2019, regardless of language, publication status, or publication date. We handsearched the reference lists of relevant papers and contacted researchers working in the field. </p> </section> <section id="CD013459-sec-0004"> <h3 class="title" id="CD013459-sec-0004">Selection criteria</h3> <p>We included cross‐sectional studies that assessed the accuracy of the F1RDT for diagnosing plague, where participants were tested with both the F1RDT and at least one reference standard. The reference standards were bacterial isolation by culture, polymerase chain reaction (PCR), and paired serology (this is a four‐fold difference in F1 antibody titres between two samples from acute and convalescent phases). </p> </section> <section id="CD013459-sec-0005"> <h3 class="title" id="CD013459-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies and extracted data. We appraised the methodological quality of each selected studies and applicability by using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS‐2) tool. When meta‐analysis was appropriate, we used the bivariate model to obtain pooled estimates of sensitivity and specificity. We stratified all analyses by the reference standard used and presented disaggregated data for forms of plague. We assessed the certainty of the evidence using GRADE. </p> </section> <section id="CD013459-sec-0006"> <h3 class="title" id="CD013459-sec-0006">Main results</h3> <p>We included eight manuscripts reporting seven studies. Studies were conducted in three countries in Africa among adults and children with any form of plague. All studies except one assessed the F1RDT produced at the Institut Pasteur of Madagascar (F1RDT‐IPM) and one study assessed a F1RDT produced by New Horizons (F1RDT‐NH), utilized by the US Centers for Disease Control and Prevention. We could not pool the findings from the F1RDT‐NH in meta‐analyses due to a lack of raw data and a threshold of the test for positivity different from the F1RDT‐IPM. </p> <p>Risk of bias was high for participant selection (retrospective studies, recruitment of participants not consecutive or random, unclear exclusion criteria), low or unclear for index test (blinding of F1RDT interpretation unknown), low for reference standards, and high or unclear for flow and timing (time of sample transportation was longer than seven days, which can lead to decreased viability of the pathogen and overgrowth of contaminating bacteria, with subsequent false‐negative results and misclassification of the target condition). </p> <p><b>F1RDT for diagnosing all forms of plague</b> </p> <p>F1RDT‐IPM pooled sensitivity against culture was 100% (95% confidence interval (CI) 82 to 100; 4 studies, 1692 participants; very low certainty evidence) and pooled specificity was 70.3% (95% CI 65 to 75; 4 studies, 2004 participants; very low‐certainty evidence). </p> <p>The performance of F1RDT‐IPM against PCR was calculated from a single study in participants with bubonic plague (see below).<br/>There were limited data on the performance of F1RDT against paired serology. </p> <p><b>F1RDT for diagnosing pneumonic plague</b> </p> <p>Performed in sputum, F1RDT‐IPM pooled sensitivity against culture was 100% (95% CI 0 to 100; 2 studies, 56 participants; very low‐certainty evidence) and pooled specificity was 71% (95% CI 59 to 80; 2 studies, 297 participants; very low‐certainty evidence). </p> <p>There were limited data on the performance of F1RDT against PCR or against paired serology for diagnosing pneumonic plague. </p> <p><b>F1RDT for diagnosing bubonic plague</b> </p> <p>Performed in bubo aspirate, F1RDT‐IPM pooled sensitivity against culture was 100% (95% CI not calculable; 2 studies, 1454 participants; low‐certainty evidence) and pooled specificity was 67% (95% CI 65 to 70; 2 studies, 1198 participants; very low‐certainty evidence). </p> <p>Performed in bubo aspirate, F1RDT‐IPM pooled sensitivity against PCR for the <i>caf1</i> gene was 95% (95% CI 89 to 99; 1 study, 88 participants; very low‐certainty evidence) and pooled specificity was 93% (95% CI 84 to 98; 1 study, 61 participants; very low‐certainty evidence). </p> <p>There were no data providing data on both F1RDT and paired serology for diagnosing bubonic plague. </p> </section> <section id="CD013459-sec-0007"> <h3 class="title" id="CD013459-sec-0007">Authors' conclusions</h3> <p>Against culture, the F1RDT appeared highly sensitive for diagnosing either pneumonic or bubonic plague, and can help detect plague in remote areas to assure management and enable a public health response. False positive results mean culture or PCR confirmation may be needed. F1RDT does not replace culture, which provides additional information on resistance to antibiotics and bacterial strains. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013459-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013459-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013459-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013459-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013459-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013459-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD013459-abs-0008">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013459-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013459-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013459-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013459-abs-0002" lang="en"> <h3>Rapid diagnostic tests for plague</h3> <p><b>Why is improving diagnosis of plague important?</b> </p> <p>Plague is a severe disease associated with high death rates. Pneumonic plague mainly affects the lungs, while bubonic plague present with painful swellings. Not recognizing plague early may result in delayed diagnosis and treatment associated with advanced illness and death, and increased disease spread. A rapid diagnostic test (RDT) could help prompt diagnosis of plague, especially in low‐resource settings. This would improve patient care and help appropriate response to avoid the disease spread. </p> <p><b>What is the aim of this review?</b> </p> <p>To assess the accuracy of the F1RDT for detecting plague in people with suspected plague. </p> <p><b>What was studied in this review?</b> </p> <p>F1RDT is a test that detects the F1 antigen, which is part of the outer surface of <i>Yersinia pestis</i>, the bacteria causing plague. The test is simple to perform and provides a result within 15 minutes. It can be performed in the pus contained in the buboes (swellings), or in the sputum (mucous coughed up from the respiratory tract) of people with suspected pneumonic plague. We measured the results of F1RDT against culture, molecular test, or serological tests. </p> <p><b>What are the main results?</b> </p> <p>Seven studies (reported in eight manuscripts) provided findings of F1RDT used in people with suspected plague in three African countries. </p> <p>For any form of plague and when compared to culture, F1RDT registered positive in 100% (sensitivity, which measures a test's ability to correctly identify a positive result for the disease) of people who had plague and registered negative in 70% of people who actually did not have plague (specificity, which measures a test's ability to correctly generate a negative result for people who do not have the condition that is being tested for). </p> <p>For pneumonic plague, sensitivity was 100% and specificity 71% compared to culture.</p> <p>For bubonic plague, sensitivity was 100% and specificity 67% compared to culture. Compared to a molecular test for bubonic plague, sensitivity was 95% and specificity 93%. </p> <p><b>How confident are we in the review</b> '<b>s results?</b> </p> <p>Overall, the reliability of the evidence was very low. Results should be interpreted with caution. There were concerns about the quality of the methodology of all included studies. Also, culture might not work well as a reference standard (comparator) when people received antibiotics before sample collection for testing. </p> <p><b>What do the results mean?</b> </p> <p>In a hypothetical population of 1000 people:</p> <p>• with symptoms of pneumonic plague where 40 of them have the disease confirmed by culture, the utilization of F1RDT would result in: 318 people to be F1RDT‐positive, of which 278 would not have pneumonic plague (called false positives); and 682 people to be F1RDT‐negative, of which none would have pneumonic plague (called false negatives). </p> <p>• with symptoms of bubonic plague where 40 of them have the disease confirmed by culture, the utilization of F1RDT would result in: 357 people to be F1RDT‐positive, of which 317 would not have bubonic plague (false positives); and 643 people to be F1RDT‐negative, of which none would have bubonic plague (false negatives). </p> <p>• with symptoms of bubonic plague where 40 of them have the disease confirmed by molecular test, the utilization of F1RDT would result in: 105 people to be F1RDT‐positive, of which 67 would not have bubonic plague (false positives); and 895 people to be F1RDT‐negative, of which two would have bubonic plague (false negatives). </p> <p><b>Who do the review</b> '<b>s results apply to?</b> </p> <p>Adults and children with suspected bubonic or pneumonic plague.</p> <p><b>What are the implications of this review?</b> </p> <p>F1RDT appears to be highly sensitive for pneumonic or bubonic plague. As a simple test that can be performed at a patient's bedside in remote and low‐resource areas, F1RDT can assist with plague diagnosis for early management, and appropriate preventive measures to avoid spread of the disease. </p> <p>The number of false positives (people with a positive F1RDT but who do not have plague) indicate that F1RDT may need to be combined with other laboratory evaluations (culture or molecular test) to confirm the diagnosis of plague. </p> <p>F1RDT does not replace culture, which provides additional information on resistance to antibiotics and bacterial strains. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The review authors searched for studies up to 15 May 2019.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013459-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013459-sec-0070"></div> <h3 class="title" id="CD013459-sec-0071">Implications for practice</h3> <section id="CD013459-sec-0071"> <p>The use of antigen F1 rapid diagnostic test (F1RDT) needs to be contextualized in order to assess its implications for practice. Two main factors may change considerably the interpretation of the accuracy findings of F1RDT. </p> <p>The first factor is the form of plague as consequences of false positives and false negatives might differ between bubonic and pneumonic plague, the latter being more severe and transmissible from human to human. Furthermore, clinical diagnosis of pneumonic plague can be more difficult than diagnosis of bubonic plague, as pneumonic plague shares signs and symptoms of other, highly prevalent, respiratory infections. This introduces uncertainty to the assessment of the pretest clinical probability; the corresponding expected numbers of false positives and false negatives would also be uncertain. In addition, the difficulties of sputum collection and obtaining good‐quality sputum samples leads to limitations of the yield of all the diagnostic techniques performed on sputum samples. These include F1RDT, but also culture and polymerase chain reaction. Diagnostic tests performed in poor‐quality samples would not detect some cases of pneumonic plague. But because this affects both rapid diagnostic tests and the reference standards (culture and polymerase chain reaction), this does not affect our pooled estimates of F1RDT against these reference standards. </p> <p>The second factor is whether the test is used during an outbreak or not, leading to different prevalence of the disease in which the test will be used, with subsequent variation in the absolute number of false positives and false negatives. </p> <p>When F1RDT is used where plague is known to occur but there is no declared ongoing outbreak, the test can have a key role in detecting the beginning of a potential outbreak. In such situations, it seems clear that F1RDT, which is easy‐to‐use, cheap, and provides fast results even in remote or resource‐restricted areas would be desirable. The specificity of the test was estimated to be 70% for detecting pneumonic plague. The number of false‐positive results is likely to lead to unnecessary social alarm with non‐negligible repercussions. However, F1RDT is being considered as a diagnostic test that may be used as an add‐on to clinical suspicion. Therefore, clinicians must consider the need of additional testing in case of positive findings. False‐negative results might contribute to the spread of the disease, and increase risk of mortality for the missed case. F1RDT showed sensitivity and NPV of 100% to detect pneumonic plague. A negative result would, therefore, rule out the disease. The broad confidence interval and the very low‐certainty evidence in the estimate oblige us to consider adding additional testing in order to rule out plague, and to take into consideration the clinical suspicion and the real epidemiological scenario. </p> <p>When F1RDT is used in a context of a declared outbreak, the test was found to present high NPV and consequently negative results help to rule out the disease and prompt us to consider alternative diagnoses. This is significant in panic situations where considerable numbers of people will present with the fear of having the disease. However, it is important that the clinician interprets the result while considering the clinical presentation and epidemiological context. False negatives might lead to a less negative impact than in the previous scenario, as the patient is likely to receive treatment independently of the result of the test (or to be closely followed) if there is high clinical suspicion of plague. However, false positives might be more of a concern as the patients will receive the diagnosis of plague and this is likely to prevent clinicians considering alternative diagnoses and adequate treatment might be delayed. False positives are also associated with unnecessary anxiety and stigma for the patients and their families. With a higher pretest probability (within a context of an outbreak), cases of false positives will increase. Therefore, for positive RDTs, the test needs to be combined with other laboratory evaluations to confirm the diagnosis, but treatment can be started. </p> <p>This review contributed to provide accuracy data for the World Health Organization (WHO) Guideline Development Group Meeting in September 2019. Both the report of the meeting and the WHO plague guidelines are expected to be in the public domain later in 2020. </p> </section> <h3 class="title" id="CD013459-sec-0072">Implications for research</h3> <section id="CD013459-sec-0072"> <p>Large, prospective, well‐designed studies that recruit people with suspicion of plague with clear inclusion and exclusion criteria will help elucidate the true accuracy of F1RDT for the detection and diagnosis of plague. False‐positive rate is likely to have been overestimated due to the imperfect reference standard for plague. Research for clarification of the true false‐positive rate of F1RDT for both pneumonic and bubonic plague is required. Clarification of estimate of pretest probability of plague for different case scenario, for RDT and other diagnostic methods will also be very valuable when determining the implication of F1RDT in practice. Research for new diagnostic techniques that do not require sputum would help overcome the limitations arising from poor‐quality samples. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013459-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013459-sec-0008"></div> <div class="table" id="CD013459-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">F1RDT against culture for all forms of plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar </p> <p><b>Reference standard:</b> culture </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 1.00 (95% CI 0.82 to 1.00). <b>Pooled specificity:</b> 0.70 (95% CI 0.65 to 0.75) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 20%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (1 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (33 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 (164 to 200)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1692 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c,d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 36)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>699 (649 to 749)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>672 (624 to 720)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>560 (520 to 600)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2004 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,d,e</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300 (250 to 350)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (240 to 336)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240 (200 to 280)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different plague prevalences (pretest probabilities): 0.1%, 4%, and 20%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test. </p> <p><b>Explanations</b> </p> <p><sup>b</sup>Downgraded two levels for risk of bias: there is high risk of bias on the patient selection and flow and timing domains for all included studies (except <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>, with low risk of bias on flow and timing domain). The included studies were retrospective case series (except <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>, which was prospective with unclear sampling methods), which was at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Not downgraded for inconsistency: there was an outlier corresponding to the pneumonic outbreak from 2017 to 2018 (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), which includes four participants. The remainder of findings showed consistency of sensitivity estimate towards 100%.<br/><sup>d</sup>Downgraded two levels for imprecision: wide 95% CI around false negatives and false positives may lead to different decisions depending on whether the upper or lower limit is assumed.<br/><sup>e</sup>Downgraded one level for indirectness: there was high concern of applicability due to exclusion of people who received antibiotics prior to sample collection (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). This can lead to false‐negative culture, which is the reference standard. In addition, the index test was performed in a central laboratory, which may not reflect the field conditions in case of an outbreak. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013459-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">F1RDT against culture for pneumonic plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of pneumonic plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of pneumonic plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar performed in sputum </p> <p><b>Reference standard:</b> sputum culture </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 1.00 (95% CI 0.00 to 1.00). <b>Pooled specificity:</b> 0.71 (95% CI 0.59 to 0.80) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Prevalence 20%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (0 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (0 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 (0 to 200)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>56 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c,d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 200)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709 (589 to 799)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>682 (566 to 768)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>568 (472 to 640)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>297 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,d,e</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>290 (200 to 410)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>278 (192 to 394)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>232 (160 to 328)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different pneumonic plague prevalences (pretest probabilities): 0.1%, 4%, and 20%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test. </p> <p><b>Explanations</b><br/><sup>b</sup>Downgraded two levels for risk of bias: there was high or unclear risk of bias on the index test and flow and timing domains for both included studies. The design of both studies was retrospective case series, which is at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Not downgraded for inconsistency: there was an outlier corresponding to the pneumonic outbreak from 2017 to 2018 (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), which included four participants. The remainder of the findings showed consistency of sensitivity estimate towards 100%.<br/><sup>d</sup>Downgraded two levels for imprecision: wide 95% CI around false negatives and false positives may lead to different decisions depending on whether the upper or lower limit is assumed. In addition, small number of participants included.<br/><sup>e</sup>Downgraded one level for indirectness: there was high concern of applicability due to exclusion of people who received antibiotics prior to sample collection. This can lead to false‐negative culture, which is the reference standard. In addition, the index test was performed in a central laboratory, which may not reflect the field conditions in case of an outbreak. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013459-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">F1RDT against culture for bubonic plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of bubonic plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of bubonic plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar performed in bubo aspirate </p> <p><b>Reference standard:</b> culture from bubo aspirate </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 1.00 (95% CI not calculable). <b>Pooled specificity:</b> 0.67 (95% CI 0.65 to 0.70) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 50%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1454 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>669 (649 to 699)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>643 (624 to 672)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>335 (325 to 350)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1198 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>330 (300 to 350)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 (288 to 336)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165 (150 to 175)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different bubonic plague prevalences (pretest probabilities): 0.1%, 4%, and 50%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test. </p> <p><b>Explanations</b><br/><sup>b</sup>Downgraded two levels for risk of bias: there was high risk of bias on the index test domain for both included studies. The design of both studies was retrospective, which is at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Downgraded one level for indirectness on false‐positive tests only. One of the included studies was at high concern of applicability due to exclusion of people who received antibiotics prior to sample collection. This can lead to false‐negative culture, which is the reference standard. In addition, the index test was performed in a central laboratory, which may not reflect the field conditions in case of an outbreak. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013459-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">F1RDT against PCR for bubonic plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of bubonic plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of bubonic plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar performed in bubo aspirate </p> <p><b>Reference standard:</b> PCR (<i>caf1</i>) from bubo aspirate </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 0.95 (95% CI 0.89 to 0.99). <b>Pooled specificity:</b> 0.93 (95% CI 0.84 to 0.98) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prevalence 50%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (1 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 (36 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>475 (445 to 495)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (0 to 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (5 to 55)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>929 (839 to 979)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>893 (806 to 941)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>465 (420 to 490)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (20 to 160)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 (19 to 154)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 (10 to 80)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different bubonic plague prevalences (pretest probabilities): 0.1%, 4%, and 50%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test; PCR: polymerase chain reaction. </p> <p><b>Explanations</b><br/><sup>b</sup>Downgraded two levels for risk of bias: there was high risk of bias on the index test domain. The estimates were assessed by one retrospective study, which is a study design at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Downgraded two levels for imprecision: wide 95% CI around false positives (and false negatives for high pretest probability of the disease) may lead to different decisions depending on whether the upper or lower limit is assumed. In addition, small number of participants included. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013459-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013459-sec-0009"></div> <section id="CD013459-sec-0010"> <h3 class="title" id="CD013459-sec-0010">Target condition being diagnosed</h3> <p>Plague has caused major historic pandemics including the 'Plague of Justinian' in the 6th century, the 'Black Death' in the 14th century (which resulted in the death of one‐third of the European population), and the 'Third Pandemic' in the 19th century (<a href="./references#CD013459-bbs2-0058" title="RasmussenS , AllentoftME , NielsenK , NielsenR , KristiansenK , WillerslevE . Early divergent strains of Yersinia pestis in Eurasia article early divergent strains of Yersinia pestis in Eurasia 5,000 years ago. Cell2015;163:571-82.">Rasmussen 2015</a>). This severe disease remains a current threat in many parts of the world, and has increased over the last three decades (<a href="./references#CD013459-bbs2-0066" title=" World Health Organization SEARO . Operational guidelines on plague surveillance, diagnosis, prevention and control. 2009. apps.who.int/iris/handle/10665/205593 (accessed prior to 3 June 2020).">WHO 2009</a>). Between 1989 and 2003, 25 countries reported 38,310 human cases of plague, including 2845 deaths (<a href="./references#CD013459-bbs2-0068" title="World Health Organization. Plague. www.who.int/csr/disease/plague/en/ (accessed 1 February 2019).">WHO 2019a</a>). Since 2000, over 95% of the burden associated with plague has been concentrated in Africa, particularly the Democratic Republic of the Congo (DRC), Madagascar, Uganda, and the United Republic of Tanzania (<a href="./references#CD013459-bbs2-0067" title="World Health Organization. Plague around the world, 2010–2015. Weekly epidemiological record2016;91(8):89-93.">WHO 2016</a>; <a href="./references#CD013459-bbs2-0068" title="World Health Organization. Plague. www.who.int/csr/disease/plague/en/ (accessed 1 February 2019).">WHO 2019a</a>). Peru and the USA also regularly report cases. Finally, although Asia is the region with the biggest natural foci of the disease, the reservoir consists of gerbils and marmots; there is a limited at‐risk population in contact with these animals, so outbreaks are sporadic (<a href="./references#CD013459-bbs2-0067" title="World Health Organization. Plague around the world, 2010–2015. Weekly epidemiological record2016;91(8):89-93.">WHO 2016</a>). As of 2017, the DRC, Madagascar, and Peru had the highest incidence of the disease. However, countries that have never experienced plague, or not experienced plague for a long while, can be affected as the limits of the existing foci are not fixed and new foci can emerge. Human plague outbreaks are continuously being reported, from Indonesia in 2007 and the DRC and Tanzania in 2014, to the outbreak of pneumonic plague more recently reported in Madagascar in 2017 (<a href="./references#CD013459-bbs2-0066" title=" World Health Organization SEARO . Operational guidelines on plague surveillance, diagnosis, prevention and control. 2009. apps.who.int/iris/handle/10665/205593 (accessed prior to 3 June 2020).">WHO 2009</a>; <a href="./references#CD013459-bbs2-0067" title="World Health Organization. Plague around the world, 2010–2015. Weekly epidemiological record2016;91(8):89-93.">WHO 2016</a>; <a href="./references#CD013459-bbs2-0068" title="World Health Organization. Plague. www.who.int/csr/disease/plague/en/ (accessed 1 February 2019).">WHO 2019a</a>). </p> <p>Plague is caused by the bacteria <i>Yersinia pestis</i>. It is primarily a vector borne zoonotic disease, affecting rodents and other wild and domestic animals. It is most commonly transmitted to humans by rodent fleas, leading to bubonic plague. Less frequently, plague can be transmitted through scratches or bites from infected animals, direct handling of infected animals, and human‐to‐human transmission by inhalation of droplets from people with pneumonic plague (<a href="./references#CD013459-bbs2-0048" title="Centers for Disease Control and Prevention. Plague. www.cdc.gov/plague/index.html (accessed 19 April 2019).">CDC 2019</a>; <a href="./references#CD013459-bbs2-0064" title="WenigerBG , WarrenAJ , ForsethV , CreelmanT , GortonJ , BarnesAM . Human bubonic plague transmitted by a domestic cat scratch. JAMA1984;251(7):927-8.">Weniger 1984</a>). </p> <p>Plague can affect both adults and children, with no differences between genders or ethnicities. However, the disease presents more frequently among people involved in activities with an increased exposure to the disease, such as hunters, veterinarians, etc. Poverty is also associated with a greater risk of contracting plague due to increased exposure to rodents. </p> <p>Plague is always a medical emergency and presents in a variety of forms, with three major clinical syndromes. Bubonic plague is the most common form and is characterized by enlarged lymph nodes with necrotic areas called buboes. Pneumonic plague is most often a fulminant form which affects the lungs and presents with cough and bloody sputum. The pneumonic form can be primary (as a result of inhalation of droplets from infected humans or animals), or secondary (as a result of the haematogenous spread of any other form of plague) (<a href="./references#CD013459-bbs2-0049" title="Center for Infectious Disease Research and Policy. Plague. Agent and pathogenesis. 2013. www.cidrap.umn.edu/infectious-disease-topics/plague (accessed 15 April 2019).">CIDRAP 2013</a>). The third major clinical form is septicaemic plague, which occurs when the infection spreads to the circulatory system; it can be primary (without buboes or pulmonary affectation), or secondary (as a result of spreading bubonic or pneumonic plague). Less commonly, plague can present as meningitis (<a href="./references#CD013459-bbs2-0057" title="PrenticeMB , RahalisonL . Plague. Lancet2007;369:1196-207.">Prentice 2007</a>). </p> <p>Although efficient antimicrobials are available, plague still has a high mortality rate as most outbreaks take place in remote places in resource‐limited settings, where proper diagnosis and treatment remains challenging (<a href="./references#CD013459-bbs2-0066" title=" World Health Organization SEARO . Operational guidelines on plague surveillance, diagnosis, prevention and control. 2009. apps.who.int/iris/handle/10665/205593 (accessed prior to 3 June 2020).">WHO 2009</a>). While bubonic plague is associated with case fatality ratios (CFRs) of 10% to 20%, pneumonic plague is highly fatal, with a CFR close to 100% if left untreated and over 50% when adequately treated with antimicrobials (<a href="./references#CD013459-bbs2-0057" title="PrenticeMB , RahalisonL . Plague. Lancet2007;369:1196-207.">Prentice 2007</a>). </p> <p>In addition to the sporadic cases and outbreaks, because of the characteristics of the disease resulting in high mortality, <i>Y pestis</i> has been used as a biological weapon and is currently a bioterrorism threat (<a href="./references#CD013459-bbs2-0048" title="Centers for Disease Control and Prevention. Plague. www.cdc.gov/plague/index.html (accessed 19 April 2019).">CDC 2019</a>). </p> <p>Due to its historical pandemics and high fatality rate, plague continues to cause fear and panic, and is sometimes associated with a disproportionate public health response, which has considerable social and economic consequences (<a href="./references#CD013459-bbs2-0054" title="MavalankarDV . Indian 'plague' epidemic: unanswered questions and key lessons. Journal of the Royal Society of Medicine1995;88:547-51.">Mavalankar 1995</a>; <a href="./references#CD013459-bbs2-0055" title="MeadPS . Plague in Madagascar – a tragic opportunity for improving public health. New England Journal of Medicine2018;378(2):106-8.">Mead 2018</a>). A clinical diagnosis of plague is difficult and not reliable. The symptoms of pneumonic plague are not specific and can be present in a person with pneumonia caused by many other pathogens. These include other bacteria such as streptococcus pneumoniae or tuberculosis, that would require different antibiotics than plague, but also viruses, such as influenza, which would require no antibiotics. A person with a swollen lymph node in an endemic area or in the context of an outbreak is more likely to receive an accurate diagnosis of bubonic plague than people with suspected pneumonic plague. However, other diagnoses need to be considered, mainly other infections that cause swollen lymph nodes such as pyogenic abscess, tularaemia, tuberculosis, lymphogranuloma venereum, and cat scratch fever. A point‐of‐care diagnostic tool that is quick to use and highly accurate would help ensure appropriate response, especially in the context of outbreaks. </p> </section> <section id="CD013459-sec-0011"> <h3 class="title" id="CD013459-sec-0011">Index test(s)</h3> <p>Rapid diagnostic tests (RDTs) detect pathogen‐specific antigens in a small quantity of different body fluids through lateral flow immunochromatography. RDTs are widely used in other diseases, such as malaria (<a href="./references#CD013459-bbs2-0069" title="World Health Organization. Rapid diagnostic tests. www.who.int/malaria/areas/diagnosis/rapid_diagnostic_tests/en/ (accessed 22 August 2019).">WHO 2019b</a>). They are usually easy to use and interpret. Indeed, they can be performed at the bedside of the patient without the requirement of special equipment or laboratory facilities. They give a simple result within around 15 minutes – positive or negative, at thresholds set by the manufacturer – that can easily be interpreted by health workers without advanced training. Therefore, RDTs are useful diagnostic tools for use at the community level and in low‐resource settings (<a href="./references#CD013459-bbs2-0069" title="World Health Organization. Rapid diagnostic tests. www.who.int/malaria/areas/diagnosis/rapid_diagnostic_tests/en/ (accessed 22 August 2019).">WHO 2019b</a>). </p> <p>In the case of plague, the RDT detects the F1 capsular antigen of <i>Y pestis</i> (F1RDT)<i>,</i> which is present in large amounts in buboes, blood, and sputum from patients infected with plague. F1RDT is the only RDT for plague that has been developed for clinical purposes that we are aware of. The test gives a semi‐quantitative result within 15 minutes according to the intensity of the line (from 1+ to 4+), although it is most commonly used as a qualitative test (positive or negative result) where positivity is interpreted from 1+ (as soon as the line is visible). The threshold for positivity will depend on the manufacturer, and is established by the lowest concentration of the F1 antigen that the test can detect. The F1RDT can be used in bubo aspirate, urine, and sputum (<a href="./references#CD013459-bbs2-0020" title="ChanteauS , RahalisonL , RatsitorahinaM , Mahafaly, RasolomaharoM , BoisierP , et al. Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick. International Journal of Medical Microbiology2000;290(3):279-83. ">Chanteau 2000a</a>); it is not usually used in blood as the pink result line would be difficult to see. Currently, the F1RDT that is mainly used in the field is produced in Madagascar. The most recent version was developed in 2001 (<a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>). Other F1RDTs for plague are produced by New Horizons in the USA (<a href="./references#CD013459-bbs2-0056" title="New Horizons. Yersinis pestis (F1). www.nhdiag.com/ypestis.shtml (accessed 22 August 2019).">New Horizons 2019</a>) and in Taiwan (<a href="./references#CD013459-bbs2-0052" title="HsuHL , ChuangCC , LiangCC , ChiaoDJ , WuHL , WuYP , et al. Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples. BMC Infectious Diseases2018;18:402.">Hsu 2018</a>), but they are not licensed for use in humans or available in the market. </p> <p>Similar to other RDTs, F1RDT should be administered by trained staff, following the manufacturer's restrictions and warnings of the test. Although no advanced training is required, clear indications must be respected. These include sample collection, sample preparation, and timely and accurate reading of the result. Storage conditions are indicated by each manufacturer and are usually easy to comply with. </p> </section> <section id="CD013459-sec-0012"> <h3 class="title" id="CD013459-sec-0012">Clinical pathway</h3> <p>People of any age affected by plague will present with non‐specific symptoms such as fever, chills, headache, or nausea; these are usually associated with lymph node swelling in case of bubonic plague, with or without cough, haemoptysis, and chest pain for pneumonic plague. While a first diagnosis of suspected plague is based on clinical findings, the definitive diagnosis requires laboratory testing. Bacteriological identification of <i>Y pestis</i> through microscopy or culture (or both) is the reference standard for a confirmed case of plague (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). <i>Y pestis</i> grows easily in standard culture media, and, while bacteriological isolation has a high specificity, it is also highly sensitive under ideal conditions. However, administration of antibiotics prior to sample collection is likely to lead to a false‐negative result. Delay in transportation from the time of collection to the central laboratory (which is not uncommon in low‐resource settings), associated or not with poor storage conditions, can lead to decreased viability of the pathogen and overgrowth of contaminating bacteria, with subsequent false‐negative results. Another confirmatory diagnosis of plague is obtained by serology with a four‐fold difference in F1 antibody titres between paired serum samples, from acute and convalescent phases. While this test is highly specific and allows diagnosis of true cases of plague, a limitation in practice is the collection of the second serum sample during the convalescence phase, as people might return to their home or work setting as soon as they feel well enough. Another technique more recently used in the diagnosis of plague is polymerase chain reaction (PCR), targeting several genes including the <i>pla</i> gene, encoding plasminogen activator, and the <i>caf1</i> gene, encoding F1 capsule antigen. This technique only requires a small amount of sample, and detects specific genes of <i>Y pestis</i> whether the bacteria is alive or dead. A person with plague who has received antibiotics prior to sample collection might present a negative culture (false negative) but a positive PCR. </p> <p>These diagnostic tests (culture, paired serology, and PCR) require technology and qualified staff, which are rarely available in resource‐limited areas. In addition, results from culture and paired serology take several days. These tests do not allow a fast confirmation or exclusion of plague diagnosis, and physicians cannot rely on them for the acute management of patients. Therefore, in practice, as soon as a case of plague is clinically suspected in an area where plague is endemic (or if the case visited an endemic area), the patient is immediately given antibiotics following collection of biological samples (blood, sputum, bubo aspirate, or a combination of these) whenever possible, and managed as a case of plague until microbiological diagnosis is confirmed or excluded, usually based on culture results. It is common that patients finish the treatment course or evolve to a fatal outcome before plague is microbiologically confirmed. In addition, public health measures are established, especially for cases of pneumonic plague, including tracing contacts and distributing chemoprophylaxis. </p> <p>The use of the F1RDT, performed for all suspected cases of plague during the first contact of the patient with healthcare facilities, would support the clinical suspicion of plague when positive, and guide physicians to consider other diseases when negative, providing valuable guidance for both clinical and public health response. </p> <section id="CD013459-sec-0013"> <h4 class="title">Prior test</h4> <p>It is very unlikely that patients will have had another diagnostic test for detecting plague prior to presentation to the health facility where the F1RDT would be performed, as the F1RDT should be performed at the first point of presentation with medical facilities. </p> </section> <section id="CD013459-sec-0014"> <h4 class="title">Role of index test</h4> <p>The role of the F1RDT is to provide bedside rapid results in the identification of people with plague, to allow prompt treatment, and to establish preventive measures in order to limit transmission of the disease to others in case of a positive result for pneumonic plague. A negative F1RDT finding would prompt clinicians to consider other diagnoses for correct management of the patient and to avoid unnecessary preventive measures that would be essential in case of plague. An easy‐to‐use and accurate F1RDT for plague would, therefore, be of considerable help in daily clinical practice for the management of people with suspicion of plague in endemic areas by providing a fast diagnosis, as microbiological confirmation of plague takes several days. The F1RDT would be used in addition to the reference standard and would not replace culture, which is fundamental for assessing circulating strains and antibiotic resistance testing. According to the specificity of the test, the F1RDT could be used as a triage tool, meaning that a negative result would definitely exclude plague, and that other tests – such as culture – would only be collected in cases with a positive result, and managed accordingly. </p> <p>The F1RDT cannot be used as a screening tool for plague in asymptomatic people, for example asymptomatic people who have been in contact with people with plague. Indeed, samples to perform the test are mainly bubo aspirate (in case of suspicion of bubonic plague) and sputum (in case of pneumonic plague) and those samples would be non‐existent in asymptomatic people. </p> </section> <section id="CD013459-sec-0015"> <h4 class="title">Alternative test(s)</h4> <p>Direct enzyme‐linked immunosorbent assay (ELISA) for detection of the F1 antigen is another test used for the diagnosis of plague. It requires equipment as well as trained personnel to perform it, and it is not easily available in low‐resource settings. </p> </section> </section> <section id="CD013459-sec-0016"> <h3 class="title" id="CD013459-sec-0016">Rationale</h3> <p>Plague is a serious illness with high mortality and rapid transmission from fleas or in between humans if control measures are not immediately implemented. Given the non‐specific symptoms of plague and the measures to be implemented in the event of a confirmed case (such as surveillance measures, identification of contacts for prophylaxis, and safe burial to avoid spread of the disease), it is crucial to make a formal diagnosis of plague as soon as possible to distinguish it from other infections with similar clinical presentation. This is particularly important for the pneumonic form of plague, where the high prevalence of other infections presenting with similar respiratory symptoms such as cough and fever makes an accurate clinical diagnosis difficult. The delay in a confirmed diagnosis may have two main repercussions. The first is at the individual level, as confirmation or exclusion of the diagnosis will help optimize the patient's management, including consideration of alternative diseases and treatments. A confirmed diagnosis allows targeted treatment with specific antibiotics. If the diagnosis is not made, patients are likely to be treated with routine empiric antibiotics which are ineffective against plague. The second is at a public health level, as pneumonic plague can be transmitted from human to human, leading to outbreaks, which are often associated with fear, panic, and sometimes with excessive measures that can lead to social and economic disruption, with considerable consequences (<a href="./references#CD013459-bbs2-0054" title="MavalankarDV . Indian 'plague' epidemic: unanswered questions and key lessons. Journal of the Royal Society of Medicine1995;88:547-51.">Mavalankar 1995</a>). </p> <p>A highly accurate and fast diagnostic test would undoubtedly be helpful. High accuracy of the test is imperative; indeed, low sensitivity (i.e. high numbers of false negatives) would lead to missed cases of plague in the situation where the test is used as a screening tool (i.e. to exclude plague diagnosis when a negative result is observed and pursue with microbiological analysis when a positive result is observed), and to initial mismanagement of the case until it is confirmed microbiologically. Low specificity would probably lead to a bigger concern. A false‐positive case might trigger unnecessary social alert, avoidable anxiety to the patients and their family, and avoidable use of resources, particularly in fragile health systems in countries where plague is endemic (<a href="./references#CD013459-bbs2-0054" title="MavalankarDV . Indian 'plague' epidemic: unanswered questions and key lessons. Journal of the Royal Society of Medicine1995;88:547-51.">Mavalankar 1995</a>; <a href="./references#CD013459-bbs2-0055" title="MeadPS . Plague in Madagascar – a tragic opportunity for improving public health. New England Journal of Medicine2018;378(2):106-8.">Mead 2018</a>). A highly specific test with a very low false‐positivity rate would allow the adequate management of all negative cases, considering them true‐negative cases. </p> <p>Another important consideration to consider while evaluating the F1RDT is the use and importance of specificity of the test in diagnosing people with suspicion of pneumonic plague in the context of an outbreak. The pneumonic form of plague is a very severe and fatal disease that can be transmitted from human to human. Contrary to the bubonic form, where the presence of buboes might facilitate the suspicion of plague, symptoms presented with the pneumonic plague are less specific. In addition, the obtention of a good sample to run the F1RDT might be more difficult in the pneumonic plague, where it might be challenging to obtain good‐quality sputum from children and from severely ill people with decreased consciousness. Performing the test in saliva instead of sputum will certainly lead to different accuracy findings, and this should be taken into account. </p> <p>The F1RDT is a simple diagnostic tool that can be performed at the bedside of the patient, with a fast result that allows prompt diagnosis and early treatment, as well as timely implementation of control measures to limit the spread of the disease. Therefore, the F1RDT has the potential to be useful to health workers, and could contribute to reducing the high mortality attributed to plague, as well as inadequate public health responses to it. However, there is no systematic review assessing the diagnostic test accuracy of the F1RDT for plague against standard diagnostic tests. Currently, a confirmed case of plague is made either by isolation of <i>Y pestis</i> (culture) or by acute and convalescent serological antibody testing (four‐fold difference in F1 antibody titres), according to World Health Organization (WHO) definitions (<a href="./references#CD013459-bbs2-0068" title="World Health Organization. Plague. www.who.int/csr/disease/plague/en/ (accessed 1 February 2019).">WHO 2019a</a>). Positivity of either test provides a reliable diagnosis of plague and can be used interchangeably to consider a case of plague (although culture is preferred in order to identify the strain and resistance pattern). Therefore, it is reasonable to assess the accuracy of the F1RDT against both these tests. With the increasing inclusion of molecular biology for the diagnosis of many infectious diseases, we thought it was relevant to also assess accuracy of the F1RDT against PCR. However, to date, there is a lack of evidence supporting the superiority of one reference test above another. </p> <p>The findings of this review will help to develop evidence‐based recommendations on the role of the F1RDT in the diagnosis of plague, which could be included in clinical guidelines about the management of plague as well as in guidelines on infection prevention and control. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013459-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013459-sec-0017"></div> <p>To determine the diagnostic accuracy of the rapid diagnostic test (RDT) based on the antigen F1 (F1RDT) for detecting plague in people with suspected disease. </p> <section id="CD013459-sec-0018"> <h3 class="title" id="CD013459-sec-0018">Secondary objectives</h3> <p>To assess the effect of forms of plague (bubonic, septicaemic, or pneumonic), specimen tested (bubonic aspirate, urine, or sputum), prior antibiotic treatment, location where the test is performed (field or laboratory studies), and threshold for detecting the disease (as set by the manufacturer) on the accuracy of the F1RDT for detecting the disease. </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013459-sec-0019" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013459-sec-0019"></div> <section id="CD013459-sec-0020"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013459-sec-0021"> <h4 class="title">Types of studies</h4> <p>We included cross‐sectional studies that assess the accuracy of the F1RDT for diagnosing plague in the laboratory or in field conditions, where patients were tested for plague with both the F1RDT and at least one of the reference standards (culture, PCR, or serology). We excluded case‐control (two‐gate cross‐sectional) studies as we aim to determine accuracy of the RDT from only one set of participants, all of them with suspected plague. </p> </section> <section id="CD013459-sec-0022"> <h4 class="title">Participants</h4> <p>We included participants (including children and pregnant women) living in or visiting areas where plague was endemic, who presented to any healthcare facility (primary, secondary, or tertiary care) with clinical suspicion of any form of plague. For studies where only a subgroup of participants was eligible for inclusion in the review, we included the study when there were disaggregated data that we could extract for that subgroup. </p> </section> <section id="CD013459-sec-0023"> <h4 class="title">Index tests</h4> <p>The index test we assessed was the F1RDT performed in any relevant sample to detect plague, this was bubo aspirate to detect bubonic plague, sputum to detect pneumonic plague, and other samples such as urine to detect septicaemic plague. </p> </section> <section id="CD013459-sec-0024"> <h4 class="title">Target conditions</h4> <p>The target condition was any form of symptomatic plague (bubonic, septicaemic, or pneumonic). </p> </section> <section id="CD013459-sec-0025"> <h4 class="title">Reference standards</h4> <p>We included studies that used one of the following reference standards to diagnose plague. </p> <p> <ul id="CD013459-list-0001"> <li> <p>Isolation of <i>Y pestis</i> by culture. </p> </li> <li> <p>PCR.</p> </li> <li> <p>Serology showing a four‐fold difference in F1 antibody titres between two paired samples.</p> </li> </ul> </p> </section> </section> <section id="CD013459-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <p>We conducted the literature search up to 15 May 2019 (27 August 2019 for PubMed), and identified potential studies regardless of language, publication status, or publication date. </p> <section id="CD013459-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases using the search terms and strategy described in <a href="./appendices#CD013459-sec-0076">Appendix 1</a>: the Cochrane Central Register of Controlled Trials (CENTRAL, published in the Cochrane Library, Issue 5, May 2019), MEDLINE (PubMed, from 1966 to 27 August 2019), Embase (Ovid; from 1949 to 15 May 2019), Science Citation Index (Web of Science, from 1900 to 15 May 2019). On 15 May 2019, we also searched Google Scholar (<a href="https://scholar.google.co.uk/" target="_blank">scholar.google.co.uk</a>), and the WHO International Clinical Trials Registry Platform (ICTRP; <a href="https://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>), and ClinicalTrials.gov for trials in progress. </p> </section> <section id="CD013459-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We searched the proceedings and abstracts of relevant conferences from the past five years: the International Symposium on Yersinia, the American Society of Tropical Medicine and Hygiene conference, and the congress of European Microbiologists. We handsearched the reference lists of relevant papers and contacted researchers working in the field. We also searched for related articles to the included studies using the PubMed "similar articles" function, on 27 August 2019. </p> </section> </section> <section id="CD013459-sec-0029"> <h3 class="title" id="CD013459-sec-0029">Data collection and analysis</h3> <section id="CD013459-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently screened all the abstracts retrieved by the search strategy, using the predefined eligibility criteria. We excluded studies that were clearly irrelevant based on the titles and abstracts. We retrieved full‐text copies of the remaining studies and applied the predefined criteria for inclusion in the review. We resolved any disagreements in assessment through discussion. We listed all studies excluded after full‐text assessment in the <a href="./references#CD013459-sec-0088" title="">Characteristics of excluded studies</a> table. We illustrated the study selection process in a PRISMA diagram (<a href="#CD013459-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD013459-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013459-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013459-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>One review author piloted the data extraction form on two studies. Based on the results of the pilot, we modified and finalized the data extraction form. Two review authors independently conducted data extraction and management, using the finalized data extraction form. We compared these data and resolved any disagreement through discussion. For each included study, we gathered information on the following (<a href="./appendices#CD013459-sec-0077">Appendix 2</a>). </p> <p> <ul id="CD013459-list-0002"> <li> <p>Setting, design, and duration of the study.</p> </li> <li> <p>Baseline characteristics of the study population and sample size.</p> </li> <li> <p>Target condition: forms of plague assessed.</p> </li> <li> <p>Index test used: name, detection target, need for sample preparation, personnel who conducted the test, training provided to personnel for conducting the test, location where test performed. </p> </li> <li> <p>Reference standard: test performed, personnel who conducted the test, training provided to personnel for conducting the test, location where test performed, conditions of storage, and transport. </p> </li> <li> <p>Results for both index and reference standard tests: missing cases, uninterpretable results, true and false positives, true and false negatives, sensitivity and specificity of index tests. </p> </li> <li> <p>Other relevant details such as source of funding.</p> </li> </ul> </p> </section> <section id="CD013459-sec-0032"> <h4 class="title">Assessment of methodological quality</h4> <p>Two review authors independently assessed the methodological quality of each included study, using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS‐2) tool, which is based on four domains: participant selection, index test, reference standard, and flow and timing (<a href="./references#CD013459-bbs2-0065" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529-36. [DOI: 10.7326/0003-4819-155-8-201110180-00009]">Whiting 2011</a>). We have tailored the tool to the context of this review (<a href="./appendices#CD013459-sec-0078">Appendix 3</a>). We answered each of the signalling questions as 'yes,' 'no,' or 'unclear,' and gave the reason for our judgement. We resolved any disagreements through discussion and through consultation with a third review author in case of persisting disagreement. </p> </section> <section id="CD013459-sec-0033"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>We stratified all analyses by the reference standard used. Within each stratum, we constructed a two‐by‐two table (containing the number of true‐positive, true‐negative, false‐positive, and false‐negative results) for each study. We entered the two‐by‐two data into Review Manager 5 (<a href="./references#CD013459-bbs2-0059" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We summarized estimates of sensitivity and specificity from each individual study on forest plots and plotted the estimates using summary receiver operating characteristic (SROC) plots. </p> <p>We calculated positive (PPV) and negative predictive value (NPV) estimates for various scenarios to help interpret the impact of F1RDT findings. There are no data reporting estimates of pretest probability of plague for the different case scenarios. Therefore, we estimated three case scenarios for each form of plague (bubonic and pneumonic plague), to the best of our knowledge and in consultation with experts in the field. The prevalence of 4% was calculated based on the number of confirmed cases of plague among notified cases of plague during the 2017 outbreak in Madagascar, as a starting point. We estimated a lower pretest probability of the disease at 0.1% for the context where plague was known to occur but where there was no declared ongoing outbreak. Finally, we estimated a higher pretest probability of the test, where the test was used in the context of a declared outbreak. In the case of bubonic plague in a context of known outbreak, a person presenting with a bubo has high probability of having the disease. Therefore, we estimated a high pretest probability of 50%. In the case of pneumonic plague, the differential diagnosis is broader than for bubonic plague, including other respiratory infections that are highly prevalent. Therefore, we estimated a pretest probability lower than for the case of bubonic plague, at 20%. </p> <p>When meta‐analysis was appropriate (given the number of studies and extent of clinical heterogeneity), we pooled results from the included studies. We used the bivariate model to obtain pooled estimates of sensitivity and specificity, as meta‐analysis was performed for a single threshold. If data were sparse and the bivariate model would not converge, we pooled data using methods described by Takwoingi and colleagues (<a href="./references#CD013459-bbs2-0062" title="TakwoingiY , GuoB , RileyRD , DeeksJJ . Performance of methods for meta-analysis of diagnostic test accuracy with few studies or sparse data. Statistical Methods in Medical Research2017;26(4):1896-911.">Takwoingi 2017</a>). All meta‐analyses were performed using the xtmelogit commands in Stata version 14 (<a href="./references#CD013459-bbs2-0061" title="Stata. Version 14. College Station (TX): StataCorp, 2015.Available at www.stata.com.">Stata 2015</a>). We plotted the pooled estimates of sensitivity and specificity using SROC plots in Review Manager 5 (<a href="./references#CD013459-bbs2-0059" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). </p> </section> <section id="CD013459-sec-0034"> <h4 class="title">Investigations of heterogeneity</h4> <p>We stratified the findings by type of reference standard used: bacterial isolation by culture, PCR, and serology showing a four‐fold difference in F1 antibody titres between two samples from acute and convalescent phases. For PCR, we described all the genes that the included studies assessed. However, when we needed to choose one gene (i.e. for meta‐analysis), we used <i>caf1</i>, which is the most relevant gene as according to experts in the field. </p> <p>We planned to assess the impact of forms of plague on the accuracy of F1RDT by performing meta‐regression. However, there were an insufficient number of studies to obtain reliable results from meta‐regression. We instead presented the findings stratified by forms of plague, as this is clinically relevant. </p> <p>We also planned to assess the impact of prior antibiotic treatment, location of performance of the F1RDT (field and central laboratory), and threshold for detecting the disease on accuracy of F1RDTs by performing subgroup analyses or meta‐regression. It was not possible to assess the impact of prior antibiotic treatment or location of performance of the F1RDT test due to scarcity of the data. Furthermore, it was not necessary to assess the impact of threshold as studies were consistent with regards to the threshold used to determine disease status. </p> </section> <section id="CD013459-sec-0035"> <h4 class="title">Sensitivity analyses</h4> <p>We planned to perform a sensitivity analysis in which we only included studies that had a low risk of bias for the four domains (patient selection, index test, reference standard, and flow and timing), or restricted to those studies at low risk of bias for patient selection only. However, it was not possible to perform this sensitivity analysis as none of the included studies were at low risk of bias for the patient selection domain. </p> <p>Two manuscripts analyzed two cohorts with overlap of participants (<a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). We included <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> in the primary analysis and performed a sensitivity analysis in which we repeated the analysis including <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>. </p> <p>We identified an outlier in the primary analysis assessing RDT against culture for all forms of plague. We performed a sensitivity analysis to explore the impact of this outlier in the pooled estimate. </p> </section> <section id="CD013459-sec-0036"> <h4 class="title">Assessment of reporting bias</h4> <p>Little is known on how to assess and detect reporting bias for diagnostic test accuracy studies (<a href="./references#CD013459-bbs2-0053" title="MacaskillP , GatsonisC , DeeksJJ , HarbordRM , TakwoingiY . Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010. Available from: srdta.cochrane.org/.">Macaskill 2010</a>). We decided not to carry out a formal assessment of publication bias using methods such as funnel plots or regression tests because such techniques have important limitations when used in reviews of diagnostic test accuracy. </p> </section> <section id="CD013459-sec-0037"> <h4 class="title">Assessment of the certainty of the evidence</h4> <p>We assessed the certainty of the evidence using GRADE and GRADEpro GDT software (<a href="./references#CD013459-bbs2-0050" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html (accessed 17 May 2019).">GRADE Handbook 2013</a>; <a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>; <a href="./references#CD013459-bbs2-0060" title="SchünemannHJ , MustafaR , BrozekJ , SteingartKR , LeeflangM , MuradMH , et al. GRADE guidelines: 21 part 2. Inconsistency, Imprecision, publication bias and other domains for rating the certainty of evidence for test accuracy and presenting it in evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2020;122:142-52. [DOI: DOI: 10.1016/j.jclinepi.2019.12.021]">Schünemann 2020</a>). We rated the certainty of the evidence as high, moderate, low, or very low by assessing four domains (risk of bias, indirectness, inconsistency, and imprecision), as follows. </p> <p> <ul id="CD013459-list-0003"> <li> <p>Risk of bias: we assessed risk of bias by using the QUADAS‐2 tool.</p> </li> <li> <p>Indirectness: we used the QUADAS‐2 tool to assess applicability concerns and looked for important differences between the populations studied, the setting, and the review question. </p> </li> <li> <p>Inconsistency: we explored inconsistency by investigating potential sources of heterogeneity, and we downgraded the certainty of the evidence when we could not explain inconsistency in the accuracy estimates. </p> </li> <li> <p>Imprecision: we considered the width of the confidence intervals (CIs) and questioned whether the truth set at the lower or upper limit of the 95% CI would change our decision. We calculated absolute numbers of true positives, true negatives, false positives, and false negatives, with ranges for these values based on the CIs of the pooled estimates of sensitivity and specificity for various prevalences of plague, and we made judgements on imprecision using these calculations. </p> </li> </ul> </p> <p>We constructed 'Summary of findings' tables, which showed the main review findings along with the certainty of the evidence. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013459-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013459-sec-0038"></div> <section id="CD013459-sec-0039"> <h3 class="title" id="CD013459-sec-0039">Results of the search</h3> <p>The search identified 727 records. We identified six additional papers by handsearching or by contacting experts. After excluding duplicates and manuscripts published before 1995 (before which F1RDT was not available), we selected 623 records for screening. We excluded 580 of them based on title and abstract. Among the 43 publications identified for full‐text review, we could not retrieve the full‐text of one of them. We assessed the full‐text of 42 articles and excluded 34 of them, with the reasons for exclusion listed in the <a href="./references#CD013459-sec-0088" title="">Characteristics of excluded studies</a> table. See <a href="#CD013459-fig-0001">Figure 1</a> for the flow diagram of the study selection process. </p> <p>Eight manuscripts met our inclusion criteria. Two manuscripts from Bertherat and colleagues reported the same plague outbreak that occurred in the DRC in 2005. As the manuscript published in 2005 did not provide additional data to the manuscript published in 2011, we merged the documents and referred to them in this review under one study ID (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>). <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> and <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> presented data on plague in Madagascar from national surveillance records, with an overlap of participants between the two manuscripts for the period between 2002 and 2007. We described the manuscripts separately in the <a href="./references#CD013459-sec-0087" title="">Characteristics of included studies</a> tables as they applied different exclusion criteria to the cohort of participants. However, we chose to include <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> in the primary analysis, as <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> presented additional data for two outbreaks with disaggregated data for bubonic and pneumonic plague. </p> <p>We described the seven studies in the <a href="./references#CD013459-sec-0087" title="">Characteristics of included studies</a> table and their key findings in <a href="#CD013459-tbl-0005">Table 1</a>. Five studies reported findings of F1RDT used in plague epidemics in Madagascar between 2000 and 2019 (<a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>; <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). One study assessed data from two outbreaks that occurred in the DRC in 2005 and 2006 (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>), and one study described performance of F1RDT from several clinics both in Madagascar and Uganda, from 2004 to 2017 (<a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>). </p> <div class="table" id="CD013459-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Setting, date</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Form of plague</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Samples for RDT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>RDT manufacturer</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Location of performance of RDT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Reference standards</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar</p> <p>Surveillance 2002–2007<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4221 (3810 analyzed, 411 unknown)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP<sup>b</sup><br/>PP<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DRC</p> <p>2 outbreaks: 2005 and 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005 outbreak: 130, RDT performed in 37</p> <p>2006 outbreak: 162, RDT performed in 96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>PCR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>2000–2001 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>671, RDT performed in 691 samples</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP (642)</p> <p>PP (20)</p> <p>Unknown (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> <p>Sputum</p> <p>Postmortem organ puncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central laboratory<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar 2004–2006</p> <p>Uganda 2004–2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least:</p> <p>BP (225)</p> <p>PP (26)</p> <p>SP (2)</p> <p>Cutaneous (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> <p>Sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New Horizons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central laboratory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>Paired serology</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>3 periods:<br/>(a) 2002–2007<br/>(b) 2017–2018<br/>(c) 2018–2019 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(A) 2468<br/>(B) 100<br/>(C) 192 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP (2503)</p> <p>PP (257)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> <p>Sputum</p> <p>Postmortem organ puncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central laboratory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>Outbreak 2011 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20, RDT performed in 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>PCR</p> <p>Paired serology</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>2007–2008 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bedside and central laboratory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>PCR</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: BP: bubonic plague; n: number; PP: pneumonic plague; PCR: polymerase chain reaction; RDT: rapid diagnostic test; SP: septicaemic plague.<br/><sup>a</sup>Additional data are reported for 1998 to 2001 and 2008 to 2018. However, for these two periods, there were no data available in order to assess diagnostic test accuracy of the RDT.<br/><sup>b</sup>No disaggregated data between BP and PP.<br/><sup>c</sup>RDTs were performed onsite and repeated at a central laboratory. However, it was unclear which findings authors used for analysis.<br/><sup>d</sup>RDTs were performed at the participant's bedside and repeated at the central laboratory. However, authors used the findings from the test performed at the central laboratory for analysis.<br/><sup>e</sup>The authors determined positive disease status when either RDT performed onsite or at the central laboratory was positive. Five cases had a positive RDT when performed onsite but negative when repeated at the central laboratory; and two cases had a negative RDT when performed onsite but positive when repeated at the central laboratory. </p> </div> </div> <p>The studies included in the primary analyses reported data from 4146 participants (<a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> excluded) including adults and children of both sex. Among them, 3989 samples were analyzed with both the index test and at least one reference standard. </p> <p>One study assessed only bubonic plague (<a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>), two studies assessed only pneumonic plague (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>), and four studies assessed all forms of plague (<a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>; <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). Samples used to perform F1RDT were bubo aspirates in participants with suspicion of bubonic plague and sputum in participants with suspicion of pneumonic plague (this was also assumed for <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> but was not clearly reported). F1RDT was also performed in a few postmortem tissue samples in two studies (<a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). The postmortem tissue samples were not relevant to this review question; however, disaggregated data were not available, so we could not exclude them from our analysis. <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> excluded cases for which time of transport of the biological samples from collection to the laboratory was superior to seven days and cases who received antibiotics prior to sample collection. </p> <p>The studies used two different F1RDT dipsticks. All studies except one (<a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>) used the F1RDT produced at the Institut Pasteur of Madagascar (F1RDT‐IPM), which is based on the combination of two anti‐F1 antibodies (B18–1 and G6–18), with a lower detection threshold of the F1 antigen of 0.5 ng/mL. <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a> assessed a F1RDT from New Horizons (F1RDT‐NH), utilized by the US Centers for Disease Control and Prevention (CDC), with a lower detection threshold of the F1 antigen of 1 ng/mL (personal communication). Additional and extensive data on performance of this test are due to be published. According to the manufacturers, both F1RDT‐IPM and F1RDT‐NH can be stored at room temperature. </p> <p>Three studies performed F1RDT in a central laboratory (<a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), and two studies both on site and in a central laboratory (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). It was also performed on site in <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>, but data included for analysis were based from the findings of those performed in the central laboratory. It was unclear where the test was performed in <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>. <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> did not report the location of performance of F1RDT, but we deduced it was in a central laboratory, as there was an overlap of participants from <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>. The people who performed the F1RDT were a trained biologist in <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>, and trained doctors, nurses, and health workers in <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>. Such information was not reported for the remaining studies. </p> <p>All studies compared F1RDT against culture, three studies against PCR (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>), and two studies against paired serology (<a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>). </p> <p>The Institut Pasteur of Madagascar, which produced one of the two dipsticks assessed in this review, supported two studies (<a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>). Other financial support or sponsors were the Institut Pasteur of Paris (<a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>), the WHO (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), and the President's Malaria Initiative/US Agency for International Development and the US Department of Homeland Security (<a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>). Four studies did not report the source of funding (<a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>; <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). </p> </section> <section id="CD013459-sec-0040"> <h3 class="title">Methodological quality of included studies</h3> <p>See the <a href="./references#CD013459-sec-0087" title="">Characteristics of included studies</a> table for the assessment of the methodological quality of each included manuscript, and <a href="#CD013459-fig-0002">Figure 2</a> for risk of bias and applicability concerns summaries. </p> <div class="figure" id="CD013459-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study." data-id="CD013459-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-02.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study. </p> </div> </div> </div> <p>In the patient selection domain, we considered all studies except one (<a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>) at high risk of bias, because recruitment of participants was not consecutive or random but based on selection of participants based on clinicians who declared cases to the national surveillance system, following a retrospective design; in addition, there were unclear exclusion criteria. In some studies, administration of antibiotics prior to sample collection was not taken into account, which could have led to a false‐negative culture when the participant truly had plague, and therefore misclassification of the test to detect the disease. We considered <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a> at unclear risk of bias as there were insufficient data to judge on this domain. Regarding applicability, five studies had low concern in the patient selection domain because the studies included the appropriate participants and settings (outbreak and national surveillance in endemic areas). Two studies were at unclear concern because there were insufficient data from <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>, and because there were limited information from the only two participants in <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>. </p> <p>In the index test domain, we judged two studies at low risk of bias because the F1RDT was interpreted without the knowledge of the results of the reference standard, and we considered them to have low concern for applicability (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>). The other five studies were at unclear risk of bias because we do not know if the result of the F1RDT was interpreted without the knowledge of the results of the reference standard. In addition, these studies did not report the way that the test was conducted, such as who performed the test, where it was performed, or the need for sample preparation. We therefore considered the conduct and interpretation of the index test to be of unclear concern for applicability in these five studies (<a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>; <a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). </p> <p>In the reference standard domain, we considered all studies at low risk of bias, as they all used culture, and four studies also used PCR, paired serology, or both, which correctly classify the target condition. For most studies, it was unclear whether the interpretation of the reference standard was blinded to the RDT result, but reference standard results are objective findings and we considered this to be at low risk to introduce bias, and at low concern of applicability. </p> <p>In the flow and timing domain, we considered three studies at high risk of bias because the time of sample transportation was longer than seven days, which can lead to decreased viability of the pathogen and overgrowth of contaminating bacteria, with subsequent false‐negative results and misclassification of the target condition (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). In addition, in one study, all participants did not receive the same reference standard (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>). We considered one study at low risk of bias in this domain as they excluded participants who received antibiotics prior to enrolment and those for whom samples took longer than seven days to reach the central laboratory (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). This was unclear for the remaining three studies. </p> </section> <section id="CD013459-sec-0041"> <h3 class="title" id="CD013459-sec-0041">Findings</h3> <p>We present the findings for all forms of plague, and then present findings disaggregated for pneumonic and bubonic plague. We could not pool the findings from the two different F1RDT used (F1RDT‐IPM and F1RDT‐NH) as the tests present different lower detection thresholds for considering the test positive. Furthermore, the only study that assessed the F1RDT‐NH used combined reference standards to consider true cases of plague (<a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>). </p> <p>We present the summary of findings including true positive, false positive, false negative, true negative, sensitivity, and specificity for each study with disaggregated data on F1RDT for diagnosing the different forms of plague against the different reference standard in <a href="#CD013459-tbl-0006">Table 2</a>. </p> <div class="table" id="CD013459-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Disaggregated findings of F1RDT for diagnosing plague</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>F1RDT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Form of plague</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TP</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>FP</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>FN</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TN</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Sensitivity (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Specificity (95% CI)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus culture</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic and pneumonic (NDD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>979</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (100 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59% (57 to 61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51% (34 to 69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2006 outbreak) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (40 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79% (70 to 87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic and pneumonic (NDD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83% (77 to 88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75% (71 to 79)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> (2002–2007) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (91 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59% (49 to 68)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (100 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67% (64 to 70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> (2017–2018) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25% (1 to 81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63% (50 to 75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (85 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82% (48 to 98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> (2018–2019) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (63 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82% (65 to 93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (94 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76% (66 to 84)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (92 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60% (50 to 69)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus PCR</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50% (1 to 99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> (<i>pla</i> and <i>caf1</i>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> (<i>caf1</i>)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95% (89 to 99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93% (84 to 98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> (<i>pla</i>)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72% (63 to 80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93% (77 to 99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> (<i>Ymt</i>)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92% (84 to 97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87% (76 to 94)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus paired serology</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (16 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus culture or paired serology</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic, pneumonic, septicaemic, cutaneous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91% (84 to 95)<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88% (83 to 93)<sup>d</sup> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test; FN: false negative; FP: false positive; IPM: Institut Pasteur of Madagascar; NDD: no disaggregated data; NH: New Horizons; NR: not reported; PCR: polymerase chain reaction; TN: true negative; TP: true positive. </p> <p>Note: we presented findings for positivity of F1RDT interpreted from 1+.<br/><sup>a</sup>The authors determined positive disease status when either RDT performed onsite or at the central laboratory was positive. Five cases had a positive RDT when performed onsite but negative when repeated at the central laboratory; and two cases had a negative RDT when performed onsite but positive when repeated at the central laboratory.<br/><sup>b</sup>There were no participants with both PCR and F1RDT findings reported from the 2006 outbreak. The gene tested by PCR during the 2005 outbreak was not specified.<br/><sup>c</sup>Three genes (<i>caf1</i> , <i>pla</i> , <i>Ymt</i>) were tested for the same group of participants. Therefore, findings for these three rows corresponded to the same cohort of participants.<br/><sup>d</sup>There was limited published available data for this study. Raw data on TP, TN, FP, and FN were not reported. The sensitivity and specificity estimates are those reported by the study authors. </p> </div> </div> <section id="CD013459-sec-0042"> <h4 class="title">1. F1RDT for diagnosing all forms of plague</h4> </section> <section id="CD013459-sec-0043"> <h4 class="title">a. F1RDT from Institut Pasteur of Madagascar</h4> <section id="CD013459-sec-0044"> <h5 class="title">F1RDT‐IPM versus culture for diagnosing all forms of plague</h5> <p>Six studies reported data on F1RDT‐IPM and culture findings for diagnosing all forms of plague. We used <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> in our primary analysis and performed sensitivity analysis with <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>. </p> <section id="CD013459-sec-0045"> <h6 class="title">Primary analysis</h6> <p>Sensitivity estimates ranged from 25% to 100% and specificity estimates ranged from 51% to 82% (<a href="#CD013459-tbl-0006">Table 2</a>). </p> <p>Two data set were not included in the meta‐analysis; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> reported zero true‐positive and zero true‐negative cases and, therefore, had no estimable sensitivity or specificity, and <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> reported a true‐positive value of zero for the 2005 outbreak and, therefore, had no estimable sensitivity. </p> <p>Four studies contributed to the final primary meta‐analysis (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2006 outbreak only); <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>) (<a href="#CD013459-fig-0003">Figure 3</a>). For the diagnosis of all forms of plague, F1RDT‐IPM pooled sensitivity against culture was 100% (95% CI 82 to 100; 4 studies, 1692 participants; very low‐certainty evidence) and specificity was 70% (95% CI 65 to 75; 4 studies, 2004 participants; very low‐certainty evidence) (<a href="./full#CD013459-tbl-0001">summary of findings Table 1</a>) (<a href="#CD013459-fig-0004">Figure 4</a>). These results were from two univariate random‐effects meta‐analyses, one for sensitivity and one for specificity. </p> <div class="figure" id="CD013459-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis.The data for Bertherat 2011 refer to the 2006 outbreak only. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD013459-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis. </p> <p>The data for <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> refer to the 2006 outbreak only. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> </div> <div class="figure" id="CD013459-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis.Pooled sensitivity: 100% (95% CI 82 to 100); pooled specificity: 70% (95% CI 65 to 75).The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis." data-id="CD013459-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis. </p> <p>Pooled sensitivity: 100% (95% CI 82 to 100); pooled specificity: 70% (95% CI 65 to 75). </p> <p>The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis. </p> </div> </div> </div> <p>By considering the forest plot, we found that sensitivity from participants with pneumonic plague in the 2017 to 2018 period reported by <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> were not in line with the rest of the sensitivity estimates by the other studies. There was a limited number of four cases in this period, all four had positive culture but only one had a positive RDT. This could have been due to several factors such as the quality of sputum samples. We decided to keep this outlier in the meta‐analysis as it did not reflect any situation inherently different from the other studies. </p> <p>Out of the 691 biological samples evaluated by <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>, RDT was performed on 35 postmortem samples from lung or liver puncture. The authors did not present disaggregated data for those samples or by forms of plague. As these samples constituted 5% of the overall samples evaluated in this study, we decided to include these findings. </p> <p>We did not investigate whether type of plague explained heterogeneity by introducing a covariate to the bivariate model, as there were an insufficient number of studies to produce reliable results. However, we did produce an SROC plot which allowed visual examination of how sensitivity and specificity varied between subgroups (<a href="#CD013459-fig-0005">Figure 5</a>). There was no clear pattern within the limited number of studies to suggest that differences existed between the different forms of plague. </p> <div class="figure" id="CD013459-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis, for investigation of heterogeneity.Each circle (all forms of plague with no disaggregated data), square (pneumonic plague), and diamond (bubonic plague) corresponds to individual study results. Their size corresponds to the sample size that contributed to the estimate of sensitivity and specificity." data-id="CD013459-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis, for investigation of heterogeneity. </p> <p>Each circle (all forms of plague with no disaggregated data), square (pneumonic plague), and diamond (bubonic plague) corresponds to individual study results. Their size corresponds to the sample size that contributed to the estimate of sensitivity and specificity. </p> </div> </div> </div> </section> <section id="CD013459-sec-0046"> <h6 class="title">Sensitivity analyses</h6> <p>We performed sensitivity analysis by excluding <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> and including <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>. Both studies were conducted from surveillance data in Madagascar, but <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> presented disaggregated data for participants with bubonic and pneumonic forms of plague for three different times (2002 to 2007, 2017 to 2018, and 2018 to 2019), and <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> presented sensitivity and specificity estimates from all forms of plague during the 2002 to 2007 period. In addition, and contrary to <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a>, <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> excluded from analysis cases for which time of transport of biological samples was more than seven days, and cases who received antibiotics prior to sample collection, which would ensure a better performance of the standard test for comparison. </p> <p>We found very similar findings to the primary analysis, with a pooled sensitivity of 100% (95% CI 70 to 100) and pooled specificity of 71% (95% CI 65 to 77) (<a href="#CD013459-fig-0006">Figure 6</a>). These results were from two univariate random‐effects meta‐analyses, one for sensitivity and one for specificity. </p> <div class="figure" id="CD013459-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Summary receiver operating characteristic (SROC) plot of 2 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, sensitivity analysis.Pooled sensitivity: 100% (95% CI 70 to 100); pooled specificity: 71% (95% CI 65 to 77).The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis." data-id="CD013459-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of 2 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, sensitivity analysis. </p> <p>Pooled sensitivity: 100% (95% CI 70 to 100); pooled specificity: 71% (95% CI 65 to 77). </p> <p>The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis. </p> </div> </div> </div> <p>We also performed sensitivity analysis by excluding the data on pneumonic plague from <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> for the 2017 to 2018 period, identified as an outlier. Although the CI for sensitivity was wider, we found no difference to the pooled results as compared with the primary analysis (pooled sensitivity of 100%, 95% CI 49 to 100 and pooled specificity of 70%, 95% CI 65 to 74). These results were from one bivariate random‐effects meta‐analysis, </p> </section> </section> <section id="CD013459-sec-0047"> <h5 class="title">F1RDT‐IPM versus PCR for diagnosing all forms of plague</h5> <p>Three studies provided data on both F1RDT‐IPM and PCR findings (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>, 2005 outbreak; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). We summarized the outcomes in <a href="#CD013459-tbl-0006">Table 2</a>. Sensitivity estimates ranged from 72% to 95% and specificity estimates ranged from 50% to 93%. The specificity estimate of 50% was based from a sample size of two participants (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>, 2005 outbreak). </p> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> assessed the performance of three different genes by PCR in the same set of 149 participants. We calculated a sensitivity of 95% and specificity of 93% for the <i>caf1</i> gene, 72% and 93% for the <i>pla</i> gene, and 92% and 87% for the <i>Ymt</i> gene. </p> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak) and <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> provided data on two participants each. It was not possible to estimate sensitivity in <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak) as the reference standard identified no cases of plague, and it was not possible to assess specificity in <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> as the reference standard only identified cases of plague. With one study remaining (<a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>), we could not perform meta‐analysis to assess the performance of F1RDT‐IPM versus PCR. </p> </section> <section id="CD013459-sec-0048"> <h5 class="title">F1RDT‐IPM versus paired serology for diagnosing all forms of plague</h5> <p>Only one study reported data with F1RDT‐IPM and paired serology findings (<a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>). Both tests (F1RDT‐IPM and paired serology) were performed on sputum in two participants, and were positive in both participants (<a href="#CD013459-tbl-0006">Table 2</a>). </p> </section> </section> <section id="CD013459-sec-0049"> <h4 class="title">b. F1RDT from New Horizons</h4> <p>One study reported findings of the F1RDT‐NH for diagnosing plague (<a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a>). </p> <p>Confirmed cases of plague were defined as isolation of <i>Y pestis</i> by culture in bubo, blood, or sputum, or 4‐fold change in titre between acute and convalescent serum samples. Participants confirmed as non‐plague were defined as <i>Y pestis</i> not isolated from culture and no significant change in titre between acute and convalescent serum samples. </p> <p>From the limited available data, there were 118 confirmed cases of plague (34 from Madagascar and 84 from Uganda); among which 109 where cases of bubonic plague. There were 136 participants tested and confirmed as non‐plague (61 from Madagascar and 75 from Uganda), among which 116 were suspected bubonic plague. </p> <p>F1RDT‐NH gives a semi‐quantitative result according to the intensity of the line in the dipstick, from 1+ to 4+. Where positivity of F1RDT‐NH was interpreted from 1+ (this is as soon as the line is visible), the test presented a sensitivity of 90.6% (95% CI 83.8 to 95.2) and a specificity of 88.0% (95% CI 82.9 to 93.3), as reported by the study authors. When evaluating F1RDT‐NH with positivity results from 2+, the test presented a sensitivity of 87.4% (95% CI 80.1 to 93.0) and a specificity of 97.7% (95% CI 93.4 to 99.5). </p> <p>Comprehensive findings of this F1RDT‐NH should be published soon (personal communication).</p> </section> <section id="CD013459-sec-0050"> <h4 class="title">2. F1RDT for diagnosing pneumonic plague</h4> </section> <section id="CD013459-sec-0051"> <h4 class="title">a. F1RDT from Institut Pasteur of Madagascar</h4> <section id="CD013459-sec-0052"> <h5 class="title">F1RDT‐IPM versus culture for diagnosing pneumonic plague</h5> <p>Three studies provided findings from both F1RDT‐IPM and culture for diagnosing pneumonic plague (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>; <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a>) (<a href="#CD013459-tbl-0006">Table 2</a>). Sensitivity was 100% with broad 95% CI (the lowest lower limit was 40%), except for the 2017 to 2018 period reported by <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> that showed a sensitivity of 25% (<a href="#CD013459-fig-0007">Figure 7</a>). There was a limited number of four cases during this period, which had positive culture but only one of them had a positive RDT. This could be due to several factors such as technical issues in preparing the sputum sample for analysis or in running the F1RDT. Specificity estimates ranged from 51% to 82%. </p> <div class="figure" id="CD013459-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of 1 F1RDT versus culture for pneumonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD013459-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of 1 F1RDT versus culture for pneumonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> </div> <p>Only two studies provided data that allowed estimation of both sensitivity and specificity of the test (<a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a>; <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), and so these two studies contributed to the meta‐analysis. Performed in sputum, F1RDT‐IPM pooled sensitivity against culture was 100% (95% CI 0 to 100; 2 studies, 56 participants; very low‐certainty evidence) and pooled specificity was 71% (95% CI 59 to 80; 2 studies, 297 participants) (<a href="./full#CD013459-tbl-0002">summary of findings Table 2</a>) (<a href="#CD013459-fig-0008">Figure 8</a>). These results were from one bivariate random‐effects meta‐analysis. </p> <div class="figure" id="CD013459-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Summary receiver operating characteristic (SROC) plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for pneumonic plague.Pooled sensitivity: 100% (95% CI 0 to 100); pooled specificity: 71% (95% CI 59 to 80).The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis." data-id="CD013459-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for pneumonic plague. </p> <p>Pooled sensitivity: 100% (95% CI 0 to 100); pooled specificity: 71% (95% CI 59 to 80). </p> <p>The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis. </p> </div> </div> </div> </section> <section id="CD013459-sec-0053"> <h5 class="title">F1RDT‐IPM versus PCR for diagnosing pneumonic plague</h5> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak) and <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> provided findings of the F1RDT‐IPM for diagnosing pneumonic plague. However, it was not possible to assess sensitivity in <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak) as there were no cases of plague identified by PCR (sensitivity cannot be calculated when there are no cases identified as this would involve dividing by zero), and it was not possible to assess specificity in <a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> as PCR only identified cases of plague (specificity cannot be calculated when only cases are identified as this would involve dividing by zero). Therefore, we did not pool data from these two studies in a meta‐analysis. </p> </section> <section id="CD013459-sec-0054"> <h5 class="title">F1RDT‐IPM versus paired serology for diagnosing pneumonic plague</h5> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> provided findings of the F1RDT‐IPM for diagnosing two participants with pneumonic plague, but it was not possible to assess specificity as the paired serology only identified cases of plague. </p> </section> </section> <section id="CD013459-sec-0055"> <h4 class="title">b. F1RDT from New Horizons</h4> <p>There were no disaggregated findings for pneumonic plague from the F1RDT‐NH test.</p> </section> <section id="CD013459-sec-0056"> <h4 class="title">3. F1RDT for diagnosing bubonic plague</h4> <p>There was no disaggregated findings for bubonic plague from the New Horizons test. The findings below are from studies assessing the F1RDT‐IPM. </p> </section> <section id="CD013459-sec-0057"> <h4 class="title">a. F1RDT from Institut Pasteur of Madagascar</h4> <section id="CD013459-sec-0058"> <h5 class="title">F1RDT‐IPM versus culture for diagnosing bubonic plague</h5> <p>Two studies performed both the F1RDT‐IPM and culture in participants with suspicion of bubonic plague (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>; <a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>) (<a href="#CD013459-tbl-0006">Table 2</a>). Sensitivity estimates were 100% for all the time periods presented by the two studies, thereby it was not possible to pool data for sensitivity estimates (<a href="#CD013459-fig-0009">Figure 9</a>). Specificity estimates ranged from 60% to 82%. F1RDT‐IPM performed in bubo aspirate for diagnosing bubonic plague showed a pooled specificity of 67% (95% CI 65 to 70; 2 studies; 1198 participants). </p> <div class="figure" id="CD013459-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of 1 F1RDT versus culture for bubonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD013459-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of 1 F1RDT versus culture for bubonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> </div> </section> <section id="CD013459-sec-0059"> <h5 class="title">F1RDT‐IPM versus PCR for diagnosing bubonic plague</h5> <p>One study assessed the performance of three different genes by PCR in the same set of 149 participants (<a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a>). We calculated the sensitivity and specificity of the F1RDT‐IPM against each of these genes, and found sensitivity of 95% (95% CI 89 to 99) and specificity of 93% (95% CI 84 to 98) for the <i>caf1</i> gene, 72% (95% CI 63 to 80) and 93% (95% CI 77 to 99) for the <i>pla</i> gene, and 92% (95% CI 84 to 97) and 87% (95% CI 76 to 94) for the <i>Ymt</i> gene (<a href="#CD013459-tbl-0006">Table 2</a>). </p> </section> <section id="CD013459-sec-0060"> <h5 class="title">F1RDT‐IPM versus paired serology for diagnosing bubonic plague</h5> <p>We found no studies assessing the accuracy of F1RDT‐IPM against paired serology for the diagnosis of bubonic plague. </p> </section> </section> <section id="CD013459-sec-0061"> <h4 class="title">b. F1RDT from New Horizons</h4> <p>There were no disaggregated findings for bubonic plague from the F1RDT‐NH test.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013459-sec-0062" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013459-sec-0062"></div> <section id="CD013459-sec-0063"> <h3 class="title" id="CD013459-sec-0063">Summary of main results</h3> <p>This systematic review of the diagnostic accuracy of F1RDT for diagnosing any form of plague in people with suspected disease summarizes the current literature and includes seven studies described in eight manuscripts. Three studies described the performance of F1RDT for diagnosing pneumonic plague and two studies for diagnosing bubonic plague, with no disaggregated data for forms of plague in three studies. The evidence came from three African countries (Madagascar, the DRC, and Uganda) with findings of F1RDT used during outbreaks or surveillance system in settings where plague is endemic. All studies except one used the F1RDT produced at the Institut Pasteur of Madagascar (F1RDT‐IPM), while the remaining study assessed a F1RDT from New Horizons (F1RDT‐NH), which is utilized by the US CDC. All studies were considered at high risk of bias for the patient domain, mainly due to the retrospective design of the studies, the absence of consecutive or random sampling with clear inclusion and exclusion criteria, or both. The major findings of this review include the following. </p> <p>For the diagnosis of any form of plague, the accuracy of F1RDT‐IPM is:</p> <p> <ul id="CD013459-list-0004"> <li> <p>against culture, sensitivity of 100% (95% CI 82 to 100; 4 studies, 1692 participants; very low‐certainty evidence) and specificity of 70% (95% CI 65 to 75; 4 studies, 2004 participants; very low certainty evidence) (<a href="./full#CD013459-tbl-0001">summary of findings Table 1</a>); </p> </li> <li> <p>against PCR, sensitivity estimates between 72% and 95% and specificity estimates between 50% and 93%, but meta‐analysis was not possible; </p> </li> <li> <p>against paired serology, very limited evidence from two participants in one study.</p> </li> </ul> </p> <p>For the diagnosis of pneumonic plague, the accuracy of F1RDT‐IPM is:</p> <p> <ul id="CD013459-list-0005"> <li> <p>against culture, sensitivity of 100% (95% CI 0 to 100; 2 studies, 56 participants; very low‐certainty evidence) and specificity of 71% (95% CI 59 to 80; 2 studies, 297 participants; very low‐certainty evidence) (<a href="./full#CD013459-tbl-0002">summary of findings Table 2</a>); </p> </li> <li> <p>against PCR, very limited evidence from four participants in two studies;</p> </li> <li> <p>against paired serology, very limited evidence from two participants in one study.</p> </li> </ul> </p> <p>The performance of F1RDT‐IPM for diagnosing bubonic plague:</p> <p> <ul id="CD013459-list-0006"> <li> <p>against culture, sensitivity of 100% (CI not calculable; 2 studies, 1454 participants; low‐certainty evidence), and specificity of 67% (95% CI 65 to 70; 2 studies, 1198 participants; very low‐certainty evidence) (<a href="./full#CD013459-tbl-0003">summary of findings Table 3</a>); </p> </li> <li> <p>against PCR, sensitivity of 95% (95% CI 89 to 99; 1 study, 88 participants; very low‐certainty evidence), and specificity of 93% (95% CI 84 to 98; 1 study, 61 participants; very low‐certainty evidence) (<a href="./full#CD013459-tbl-0004">summary of findings Table 4</a>); </p> </li> <li> <p>against paired serology, no data.</p> </li> </ul> </p> <p>The performance of the F1RDT‐NH for diagnosing any form of plague against combined culture or paired serology showed sensitivity of 91% (95% CI 84 to 95) and specificity of 88% (95% CI 83 to 93), as reported by the study authors. When evaluating the F1RDT‐NH with positivity results from 2+, the sensitivity decreased to 87% (95% CI 80 to 93) and the specificity increased to 98% (95% CI 93 to 100). </p> <section id="CD013459-sec-0064"> <h4 class="title">F1RDT for diagnosing pneumonic plague</h4> <p>Early diagnosis of pneumonic plague is critical so that prompt treatment is started (pneumonic plague is associated with high fatality rate if left untreated) and so that preventive measures are established to limit transmission of the disease (pneumonic plague can be transmitted from human to human by inhalation of respiratory droplets produced by coughing). </p> <p>Against culture results, sensitivity appeared high (100%) but three participants testing negative in one outbreak in a meta‐analysis that included data for 56 cases resulted in very wide CIs (0 to 100). The specificity was 71% (95% CI 59 to 80). However, these estimates came from a small number of participants and there was very low‐certainty evidence. </p> <p>We used different case scenarios where pretest probability of plague varied from 0.1% to 4% to 20% to simulate scenarios where F1RDT could be used in plague endemic areas and in situations where an outbreak is in progress (<a href="./full#CD013459-tbl-0002">summary of findings Table 2</a>). This numerical approach should be interpreted with caution due to the limitations cited above. </p> <p> <ul id="CD013459-list-0007"> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where one (0.1%) of them actually had pneumonic plague identified by culture, we estimated that the test would correctly diagnose the one person with pneumonic plague (1 true positive, 95% CI 0 to 1) and would not miss any people with pneumonic plague (0 false negatives, 95% CI 0 to 1), but would diagnose 290 people with pneumonic plague who were culture negative (290 false positives, 95% CI 200 to 410). </p> </li> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where 40 (4%) of them actually had pneumonic plague identified by culture, we estimated that the test would correctly diagnose all 40 people (40 true positives, 95% CI 0 to 40) and would not miss any people with plague (0 false negative, 95% CI 0 to 40), but would diagnose 278 people with pneumonic plague who were culture negative (278 false positives, 95% CI 192 to 394). In this case scenario, the PPV would be 12.6%. This means that among 318 people with positive F1RDT, 12.6% of them would actually have pneumonic plague (see <a href="#CD013459-fig-0010">Figure 10</a>). The NPV would be 100%, which means that among the 682 people with negative F1RDT, all of them truly will not have pneumonic plague. </p> </li> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where 200 (20%) of them actually had pneumonic plague identified by culture, we estimated that the test would correctly diagnose all 200 people (200 true positives, 95% CI 0 to 200) and would not miss any people with plague (0 false negative, 95% CI 0 to 200), but would diagnose 232 people with pneumonic plague who were culture negative (232 false positives, 95% CI 160 to 328). </p> </li> </ul> </p> <div class="figure" id="CD013459-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Flow diagram summarizing the main results in a hypothetical cohort with 4% of people with pneumonic plague (adapted from van Hoving 2019).F1RDT: F1 antigen rapid diagnostic test." data-id="CD013459-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-10.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram summarizing the main results in a hypothetical cohort with 4% of people with pneumonic plague (adapted from <a href="./references#CD013459-bbs2-0063" title="vanHovingDJ , GrieselR , MeintjesG , TakwoingiY , MaartensG , OchodoEA . Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals. Cochrane Database of Systematic Reviews2019, Issue 9. [DOI: 10.1002/14651858.CD012777]">van Hoving 2019</a>). </p> <p>F1RDT: F1 antigen rapid diagnostic test.</p> </div> </div> </div> <p>The high sensitivity associated with F1RDT for diagnosing pneumonic plague means that the test would detect all cases of pneumonic plague and would not miss any people with diagnosis of pneumonic plague. The high NPV means that if result of F1RDT is negative, pneumonic plague can be ruled out. However, the relatively low specificity and low PPV associated with F1RDT are of concern for the potential significant repercussions in the context of this disease. False positives mean that people who do not have plague will be considered as having plague, with repercussion for both the person (missing the true diagnosis, unnecessary anxiety and stigma related to the diagnosis of plague) and for society (unnecessary social alert and use of economic resources) (<a href="#CD013459-fig-0010">Figure 10</a>). </p> <p>The high apparent level of false positives with culture as the reference standard may actually be a result of people with plague testing culture negative; prior antibiotic use, for example, could cause this. Culture is known to be an imperfect reference standard for plague, as reminded in <a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> where authors mentioned that "negative culture results might have resulted from administration of antimicrobial drugs by local health officials before sampling, whereas F1RDT results remained positive &gt;3 weeks after treatment initiation." This would result in an underestimation of the specificity. </p> <p>There were insufficient data to make any estimates against PCR or paired serology as reference standard. </p> </section> <section id="CD013459-sec-0065"> <h4 class="title">F1RDT for diagnosing bubonic plague</h4> <p>Early and correct diagnosis of bubonic plague is essential for correct management of the patient and adequate public health measures and rodent control. </p> <p>Two studies assessed F1RDT against culture, with a mean sensitivity of 100% (95% CI not calculable), and specificity of 67% (95% CI 65 to 70). However, the evidence was low certainty for sensitivity and very‐low certainty for specificity. </p> <p>One study assessed F1RDT against PCR for three genes (<i>caf1</i> , <i>pla</i> , <i>Ymt</i> ). For <i>caf1</i>, which is considered the most relevant gene according to experts in the field, sensitivity was 95% (95% CI 89 to 99) and specificity was 93% (95% CI 84 to 98). </p> <p>We used different case scenarios where pretest probability of plague varied from 0.1% to 4% to 50% to simulate scenarios where F1RDT could be used in plague endemic areas and in situations where an outbreak is in progress. This numerical approach should be interpreted with caution due to the limitations cited above. </p> <p>When true cases of bubonic plague were diagnosed with culture, the main findings were the following (<a href="./full#CD013459-tbl-0003">summary of findings Table 3</a>). </p> <p> <ul id="CD013459-list-0008"> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where one (0.1%) of them actually had bubonic plague identified by culture, we estimated that the test would correctly diagnose the one person with bubonic plague (1 true positive, 95% CI not calculable) and would not miss any people with bubonic plague (0 false negatives, 95% CI not calculable), but would diagnose 330 people with bubonic plague who were culture negative (330 false positives, 95% CI 300 to 350). </p> </li> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where 40 (4%) of them actually had bubonic plague identified by culture, we estimated that the test would correctly diagnose all 40 people (40 true positives, 95% CI not calculable) and would not miss any people with bubonic plague (0 false negatives, 95% CI not calculable), but would diagnose 317 people with bubonic plague who were culture negative (317 false positives, 95% CI 288 to 336). In this case scenario, the (PPV would be 11.2%. This means that among 357 people with positive F1RDT, 11.2% of them would actually have bubonic plague. The NPV would be 100%, which means that among the 643 people with negative F1RDT, all of them truly would not have bubonic plague. </p> </li> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where 500 (50%) of them actually had bubonic plague identified by culture, we estimated that the test would correctly diagnose all 500 people (500 true positives, 95% CI not calculable) and would not miss any people with bubonic plague (0 false negative, 95% CI not calculable), but would diagnose 165 people with bubonic plague who were culture negative (165 false positives, 95% CI 150 to 175). </p> </li> </ul> </p> <p>When true cases of bubonic plague are diagnosed with PCR targeting the <i>caf1</i> gene, the main findings are the following (<a href="./full#CD013459-tbl-0004">summary of findings Table 4</a>). </p> <p> <ul id="CD013459-list-0009"> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where one (0.1%) of them actually had bubonic plague identified by PCR, we estimated that the test would correctly diagnose the one person with bubonic plague (1 true positive, 95% CI 1 to 1) and would not miss any people with bubonic plague (0 false negatives, 95% CI 0 to 0), but would diagnose 70 people with bubonic plague who were PCR negative (70 false positives, 95% CI 20 to 160). </p> </li> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where 40 (4%) of them actually had bubonic plague identified by PCR, we estimated that the test would correctly diagnose 38 people (38 true positives, 95% CI 36 to 40), but would miss two people with bubonic plague (2 false negatives, 95% CI 0 to 4) and would diagnose 67 people with bubonic plague who were PCR negative (67 false positives, 95% CI 19 to 154). In this case scenario, the PPV would be 36.1%. This means that among 105 people with positive F1RDT, 36.1% of them would actually have bubonic plague. The NPV would be 99.8%, which means that among the 895 people with negative F1RDT, 99.8% of them truly would not have bubonic plague. </p> </li> <li> <p>If F1RDT was used in a hypothetical cohort of 1000 people with symptoms where 500 (50%) of them actually had bubonic plague identified by PCR, we estimated that the test would correctly diagnose 475 people (475 true positives, 95% CI 445 to 495), but it would miss 25 people with bubonic plague (25 false negatives, 95% CI 5 to 55) and would diagnose 35 people with bubonic plague who were PCR negative (35 false positives, 95% CI 10 to 80). </p> </li> </ul> </p> <p>Similar to its performance for diagnosing pneumonic plague, the high sensitivity associated with F1RDT for diagnosing bubonic plague means that the test would detect all cases (when compared to culture) or most cases (when compared to PCR) of bubonic plague. The high NPV means that when F1RDT shows a negative finding, bubonic plague can be ruled out. </p> <p>We found higher specificity and PPV estimates when F1RDT was compared to PCR than to culture. This further demonstrates that culture is an imperfect reference standard. In the case of prior use of antibiotics, culture is likely to become negative while PCR might still be positive by detecting DNA of <i>Y pestis</i> after several doses of antibiotics. </p> <p>We found no studies that determined the performance of F1RDT against paired serology for diagnosing bubonic plague. </p> </section> </section> <section id="CD013459-sec-0066"> <h3 class="title" id="CD013459-sec-0066">Strengths and weaknesses of the review</h3> <section id="CD013459-sec-0067"> <h4 class="title">Strengths and weaknesses of the included studies</h4> <p>The small number of studies and participants included in the analyses is a major limitation of the review with regards to estimation of accuracy. The sensitivity estimates had broad CIs, which underlies the imprecision of the estimates. The lower and higher values of the CIs provide very different scenarios that would lead to different decisions in practice. The study design of the included studies contributing to the high risk of selection bias further weakened our confidence in the results – we judged all included studies at high risk of bias in the patient selection domain when applying the QUADAS‐2 tool. We found no study that assessed the accuracy of F1RDT for diagnosing plague by prospectively recruiting consecutive patients with clear inclusion and exclusion criteria. There are also some limitations with regards to the reference standards. Although they were considered at low risk of introducing bias due to the objective results they provided, culture could be considered as an imperfect reference standard when antibiotics are given prior to sample collection, and there is a lack of standardized targeted gene for identification <i>Y pestis</i> with PCR. </p> </section> <section id="CD013459-sec-0068"> <h4 class="title">Strengths and weaknesses of the review process</h4> <p>The findings of this review are based on a comprehensive literature search with no restriction in language, strict inclusion criteria, duplicate data extraction, and rigorous assessment of risk of bias using the QUADAS‐2 tool tailored to our review question. The inclusion of unpublished data at the time of conducting the review constitutes a strength of the review process. </p> <p>We attempted to contact study authors when there was poor reporting that limited data extraction or our judgement on applicability of the findings. </p> <p>The prevalence of plague is not well established. For the hypothetical cohort scenarios, we presented above and in the 'Summary of finding' tables, we chose different values from 0.1% to 50% corresponding to pretest probability in order to contemplate different scenarios. For this, we considered using RDT where there was no ongoing outbreak (lower pretest probability) or where there was ongoing outbreak (higher pretest probability), as well as the form of plague (signs and symptoms of bubonic plague are more specific than those of pneumonic plague, therefore the pretest probability of plague when conducting F1RDT in a person with fever and a bubo in an endemic area is likely to be higher than when conducting F1RDT in a person with fever and productive cough). </p> <p>Sources of heterogeneity could not be explored due to the scarcity of the included studies and participants. However, we calculated the test accuracy and presented the findings disaggregated by form of plague and against different reference standards that are commonly used in practice. </p> </section> </section> <section id="CD013459-sec-0069"> <h3 class="title" id="CD013459-sec-0069">Applicability of findings to the review question</h3> <p>Inclusion criteria of this review were broad and, as such, were a good representation of the real scenarios in which F1RDT would be used. Overall, we had low concern of the applicability of findings from the included studies to our review question, when assessed with the tailored QUADAS‐2 tool. </p> <p>The participant characteristics and settings matched our review question. For the reference standard domain, all the studies had low concern for applicability. With regards to the index test domain, F1RDT was conducted in central laboratories for the majority of participants who contributed to the primary analyses. In most cases, it was unclear whether the index test was performed by specialized and trained staff or by healthcare workers who may not have been adequately trained or may not have used a rapid test by immunochromatography previously. Therefore, it is possible that the accuracy of the test is lower when used on the bedside of the patients in the field. Another aspect to consider is the sample collection. Collection of sputum from a sick person during an outbreak is often performed in a context of panic and can be challenging, leading to collection of saliva instead. In the case of people with suspected bubonic plague, the obtention of pus from the bubo is usually simpler but can also be challenging depending on the size of the bubo. However, this is likely to affect the yield of all diagnostic tests performed in the relevant sample (sputum or bubo aspirate), including F1RDT, culture, and PCR, with no expected repercussion on the accuracy of the F1RDT against culture or against PCR. Poor‐quality samples (sputum or bubo aspirate) may lead to a decreased sensitivity when comparing the F1RDT against paired serology (performed in blood samples). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013459-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013459-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study." data-id="CD013459-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-02.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-02.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis.The data for Bertherat 2011 refer to the 2006 outbreak only. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD013459-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis. </p> <p>The data for <a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> refer to the 2006 outbreak only. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis.Pooled sensitivity: 100% (95% CI 82 to 100); pooled specificity: 70% (95% CI 65 to 75).The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis." data-id="CD013459-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-04.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis. </p> <p>Pooled sensitivity: 100% (95% CI 82 to 100); pooled specificity: 70% (95% CI 65 to 75). </p> <p>The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis, for investigation of heterogeneity.Each circle (all forms of plague with no disaggregated data), square (pneumonic plague), and diamond (bubonic plague) corresponds to individual study results. Their size corresponds to the sample size that contributed to the estimate of sensitivity and specificity." data-id="CD013459-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-05.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of one F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, primary analysis, for investigation of heterogeneity. </p> <p>Each circle (all forms of plague with no disaggregated data), square (pneumonic plague), and diamond (bubonic plague) corresponds to individual study results. Their size corresponds to the sample size that contributed to the estimate of sensitivity and specificity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Summary receiver operating characteristic (SROC) plot of 2 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, sensitivity analysis.Pooled sensitivity: 100% (95% CI 70 to 100); pooled specificity: 71% (95% CI 65 to 77).The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis." data-id="CD013459-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-06.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of 2 F1 antigen rapid diagnostic test (F1RDT) versus culture for all forms of plague, sensitivity analysis. </p> <p>Pooled sensitivity: 100% (95% CI 70 to 100); pooled specificity: 71% (95% CI 65 to 77). </p> <p>The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Forest plot of 1 F1RDT versus culture for pneumonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD013459-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-07.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of 1 F1RDT versus culture for pneumonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Summary receiver operating characteristic (SROC) plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for pneumonic plague.Pooled sensitivity: 100% (95% CI 0 to 100); pooled specificity: 71% (95% CI 59 to 80).The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis." data-id="CD013459-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-08.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Summary receiver operating characteristic (SROC) plot of 1 F1 antigen rapid diagnostic test (F1RDT) versus culture for pneumonic plague. </p> <p>Pooled sensitivity: 100% (95% CI 0 to 100); pooled specificity: 71% (95% CI 59 to 80). </p> <p>The solid black dot corresponds to the pooled estimate of sensitivity and specificity; the black circles show individual study results and their size corresponds to the sample size of the study contributing to the analysis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Forest plot of 1 F1RDT versus culture for bubonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive." data-id="CD013459-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-09.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of 1 F1RDT versus culture for bubonic plague. CI: confidence interval; FN: false negative; FP: false positive; TN: true negative; TP: true positive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Flow diagram summarizing the main results in a hypothetical cohort with 4% of people with pneumonic plague (adapted from van Hoving 2019).F1RDT: F1 antigen rapid diagnostic test." data-id="CD013459-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-10.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Flow diagram summarizing the main results in a hypothetical cohort with 4% of people with pneumonic plague (adapted from <a href="./references#CD013459-bbs2-0063" title="vanHovingDJ , GrieselR , MeintjesG , TakwoingiY , MaartensG , OchodoEA . Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals. Cochrane Database of Systematic Reviews2019, Issue 9. [DOI: 10.1002/14651858.CD012777]">van Hoving 2019</a>). </p> <p>F1RDT: F1 antigen rapid diagnostic test.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-FIG-10.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-TST-001" target="_blank"><b></b></a></p> </div><img alt="F1RDT versus culture for all forms of plague, primary analysis" data-id="CD013459-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-TST-001.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-TST-001.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>F1RDT versus culture for all forms of plague, primary analysis</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references#CD013459-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-TST-001.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-TST-002" target="_blank"><b></b></a></p> </div><img alt="F1RDT versus culture for all forms of plague, sensitivity analysis 1" data-id="CD013459-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-TST-002.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-TST-002.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 2</div> <div class="figure-caption"> <p>F1RDT versus culture for all forms of plague, sensitivity analysis 1</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references#CD013459-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-TST-002.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013459-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/urn:x-wiley:14651858:media:CD013459:CD013459-TST-003" target="_blank"><b></b></a></p> </div><img alt="F1RDT versus culture for all forms of plague, sensitivity analysis 2" data-id="CD013459-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-TST-003.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_t/tCD013459-TST-003.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 3</div> <div class="figure-caption"> <p>F1RDT versus culture for all forms of plague, sensitivity analysis 2</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references#CD013459-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/media/CDSR/CD013459/image_n/nCD013459-TST-003.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013459-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">F1RDT against culture for all forms of plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar </p> <p><b>Reference standard:</b> culture </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 1.00 (95% CI 0.82 to 1.00). <b>Pooled specificity:</b> 0.70 (95% CI 0.65 to 0.75) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 20%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (1 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (33 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 (164 to 200)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1692 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c,d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 36)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>699 (649 to 749)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>672 (624 to 720)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>560 (520 to 600)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2004 (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,d,e</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300 (250 to 350)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>288 (240 to 336)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>240 (200 to 280)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different plague prevalences (pretest probabilities): 0.1%, 4%, and 20%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test. </p> <p><b>Explanations</b> </p> <p><sup>b</sup>Downgraded two levels for risk of bias: there is high risk of bias on the patient selection and flow and timing domains for all included studies (except <a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>, with low risk of bias on flow and timing domain). The included studies were retrospective case series (except <a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a>, which was prospective with unclear sampling methods), which was at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Not downgraded for inconsistency: there was an outlier corresponding to the pneumonic outbreak from 2017 to 2018 (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), which includes four participants. The remainder of findings showed consistency of sensitivity estimate towards 100%.<br/><sup>d</sup>Downgraded two levels for imprecision: wide 95% CI around false negatives and false positives may lead to different decisions depending on whether the upper or lower limit is assumed.<br/><sup>e</sup>Downgraded one level for indirectness: there was high concern of applicability due to exclusion of people who received antibiotics prior to sample collection (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>). This can lead to false‐negative culture, which is the reference standard. In addition, the index test was performed in a central laboratory, which may not reflect the field conditions in case of an outbreak. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">F1RDT against culture for all forms of plague</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013459-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">F1RDT against culture for pneumonic plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of pneumonic plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of pneumonic plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar performed in sputum </p> <p><b>Reference standard:</b> sputum culture </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 1.00 (95% CI 0.00 to 1.00). <b>Pooled specificity:</b> 0.71 (95% CI 0.59 to 0.80) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign=""> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Prevalence 20%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (0 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40 (0 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 (0 to 200)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>56 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c,d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 200)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>709 (589 to 799)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>682 (566 to 768)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>568 (472 to 640)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>297 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,d,e</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having pneumonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>290 (200 to 410)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>278 (192 to 394)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>232 (160 to 328)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different pneumonic plague prevalences (pretest probabilities): 0.1%, 4%, and 20%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test. </p> <p><b>Explanations</b><br/><sup>b</sup>Downgraded two levels for risk of bias: there was high or unclear risk of bias on the index test and flow and timing domains for both included studies. The design of both studies was retrospective case series, which is at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Not downgraded for inconsistency: there was an outlier corresponding to the pneumonic outbreak from 2017 to 2018 (<a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a>), which included four participants. The remainder of the findings showed consistency of sensitivity estimate towards 100%.<br/><sup>d</sup>Downgraded two levels for imprecision: wide 95% CI around false negatives and false positives may lead to different decisions depending on whether the upper or lower limit is assumed. In addition, small number of participants included.<br/><sup>e</sup>Downgraded one level for indirectness: there was high concern of applicability due to exclusion of people who received antibiotics prior to sample collection. This can lead to false‐negative culture, which is the reference standard. In addition, the index test was performed in a central laboratory, which may not reflect the field conditions in case of an outbreak. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">F1RDT against culture for pneumonic plague</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013459-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">F1RDT against culture for bubonic plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of bubonic plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of bubonic plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar performed in bubo aspirate </p> <p><b>Reference standard:</b> culture from bubo aspirate </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 1.00 (95% CI not calculable). <b>Pooled specificity:</b> 0.67 (95% CI 0.65 to 0.70) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="top"> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Prevalence 50%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1454 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝</p> <p><b>Low</b><sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>669 (649 to 699)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>643 (624 to 672)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>335 (325 to 350)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1198 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>330 (300 to 350)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 (288 to 336)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165 (150 to 175)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different bubonic plague prevalences (pretest probabilities): 0.1%, 4%, and 50%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test. </p> <p><b>Explanations</b><br/><sup>b</sup>Downgraded two levels for risk of bias: there was high risk of bias on the index test domain for both included studies. The design of both studies was retrospective, which is at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Downgraded one level for indirectness on false‐positive tests only. One of the included studies was at high concern of applicability due to exclusion of people who received antibiotics prior to sample collection. This can lead to false‐negative culture, which is the reference standard. In addition, the index test was performed in a central laboratory, which may not reflect the field conditions in case of an outbreak. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">F1RDT against culture for bubonic plague</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013459-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">F1RDT against PCR for bubonic plague</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Review question:</b> what is the diagnostic accuracy of F1RDT for the diagnosis of bubonic plague in adults and children? </p> <p><b>Setting:</b> populations where plague has been known to occur and populations where an outbreak is in progress </p> <p><b>Patient or population:</b> adults and children with suspicion of bubonic plague </p> <p><b>Index test:</b> F1RDT from Institut Pasteur of Madagascar performed in bubo aspirate </p> <p><b>Reference standard:</b> PCR (<i>caf1</i>) from bubo aspirate </p> <p><b>Study design:</b> retrospective reports </p> <p><b>Pooled sensitivity:</b> 0.95 (95% CI 0.89 to 0.99). <b>Pooled specificity:</b> 0.93 (95% CI 0.84 to 0.98) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Test result</b> </p> </th> <th align="" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Number of results per 1000 participants tested (95% CI)<sup>a</sup> </b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Number of participants (studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prevalence 0.1%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prevalence 4%</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Prevalence 50%</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True positives</b> (participants correctly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (1 to 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38 (36 to 40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>475 (445 to 495)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False negatives</b> (participants incorrectly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (0 to 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (5 to 55)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>True negatives</b> (participants correctly classified as not having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>929 (839 to 979)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>893 (806 to 941)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>465 (420 to 490)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝</p> <p><b>Very low</b><sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>False positives</b> (participants incorrectly classified as having bubonic plague) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70 (20 to 160)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 (19 to 154)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 (10 to 80)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>The table displays normalized frequencies within a hypothetical cohort of 1000 people at three different bubonic plague prevalences (pretest probabilities): 0.1%, 4%, and 50%. We selected prevalence values based on the range of prevalence observed across the included studies and on hypothetical field situations. We estimated confidence intervals based on those around the point estimates for pooled sensitivity and specificity. </p> <p><b>Abbreviations</b><br/>CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test; PCR: polymerase chain reaction. </p> <p><b>Explanations</b><br/><sup>b</sup>Downgraded two levels for risk of bias: there was high risk of bias on the index test domain. The estimates were assessed by one retrospective study, which is a study design at high risk of introducing bias for evaluating diagnostic test accuracy.<br/><sup>c</sup>Downgraded two levels for imprecision: wide 95% CI around false positives (and false negatives for high pretest probability of the disease) may lead to different decisions depending on whether the upper or lower limit is assumed. In addition, small number of participants included. </p> <p><b>GRADE certainty of evidence</b> (<a href="./references#CD013459-bbs2-0051" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 17 May 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.Available at gradepro.org.">GRADEpro GDT 2015</a>)<br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">F1RDT against PCR for bubonic plague</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013459-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Setting, date</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>n</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Form of plague</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Samples for RDT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>RDT manufacturer</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Location of performance of RDT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Reference standards</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar</p> <p>Surveillance 2002–2007<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4221 (3810 analyzed, 411 unknown)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP<sup>b</sup><br/>PP<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DRC</p> <p>2 outbreaks: 2005 and 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2005 outbreak: 130, RDT performed in 37</p> <p>2006 outbreak: 162, RDT performed in 96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>PCR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>2000–2001 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>671, RDT performed in 691 samples</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP (642)</p> <p>PP (20)</p> <p>Unknown (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> <p>Sputum</p> <p>Postmortem organ puncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central laboratory<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar 2004–2006</p> <p>Uganda 2004–2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least:</p> <p>BP (225)</p> <p>PP (26)</p> <p>SP (2)</p> <p>Cutaneous (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> <p>Sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New Horizons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central laboratory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>Paired serology</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>3 periods:<br/>(a) 2002–2007<br/>(b) 2017–2018<br/>(c) 2018–2019 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(A) 2468<br/>(B) 100<br/>(C) 192 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP (2503)</p> <p>PP (257)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> <p>Sputum</p> <p>Postmortem organ puncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Central laboratory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>Outbreak 2011 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20, RDT performed in 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>PCR</p> <p>Paired serology</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Madagascar<br/>2007–2008 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubo aspirate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Institut Pasteur Madagascar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bedside and central laboratory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Culture</p> <p>PCR</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>Abbreviations: BP: bubonic plague; n: number; PP: pneumonic plague; PCR: polymerase chain reaction; RDT: rapid diagnostic test; SP: septicaemic plague.<br/><sup>a</sup>Additional data are reported for 1998 to 2001 and 2008 to 2018. However, for these two periods, there were no data available in order to assess diagnostic test accuracy of the RDT.<br/><sup>b</sup>No disaggregated data between BP and PP.<br/><sup>c</sup>RDTs were performed onsite and repeated at a central laboratory. However, it was unclear which findings authors used for analysis.<br/><sup>d</sup>RDTs were performed at the participant's bedside and repeated at the central laboratory. However, authors used the findings from the test performed at the central laboratory for analysis.<br/><sup>e</sup>The authors determined positive disease status when either RDT performed onsite or at the central laboratory was positive. Five cases had a positive RDT when performed onsite but negative when repeated at the central laboratory; and two cases had a negative RDT when performed onsite but positive when repeated at the central laboratory. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013459-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Disaggregated findings of F1RDT for diagnosing plague</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>F1RDT</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Form of plague</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TP</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>FP</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>FN</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TN</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Sensitivity (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Specificity (95% CI)</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus culture</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0001" title="AndrianaivoarimananaV , PiolaP , WagnerDM , RakotomananaF , MaheriniainaV , AndrianalimananaS , et al. Trends of human plague, Madagascar, 1998–2016. Emerging Infectious Diseases2019;25(2):220-8. ">Andrianaivoarimanana 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic and pneumonic (NDD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>979</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (100 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59% (57 to 61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51% (34 to 69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2006 outbreak) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (40 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79% (70 to 87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0003" title="ChanteauS , RahalisonL , RalafiarisoaL , FoulonJ , RatsitorahinaM , RatsifasoamananaL , et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet2003;361(9353):211-6. ">Chanteau 2003a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic and pneumonic (NDD)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83% (77 to 88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75% (71 to 79)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> (2002–2007) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (91 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59% (49 to 68)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1328</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (100 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67% (64 to 70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> (2017–2018) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25% (1 to 81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63% (50 to 75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (85 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82% (48 to 98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD013459-bbs2-0005" title="RajerisonM , MeloccoM , AndrianaivoarimananaV , RahajandraibeS , RakotoarimananaF , SpiegelA , et al. Performance of plague rapid diagnostic test compared to bacteriology: a retrospective analysis of the data collected in Madagascar. BMC Infectious Diseases2020;20:90. ">Rajerison 2020</a> (2018–2019) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (63 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82% (65 to 93)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (94 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76% (66 to 84)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (92 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60% (50 to 69)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus PCR</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0002" title="BertheratE , LamineKM , FormentyP , ThullierP , MondongeV , MitifuA , et al. Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge [Epidémie de peste pulmonaire dans un camp minier de la République Démocratique du Congo: Le réveil brutal d'un vieux fléau]. Medecine Tropicale2005;65(6):511-4. BertheratE , ThullierP , ShakoJC , EnglandK , KoneML , ArntzenL , et al. Lessons learned about pneumonic plague diagnosis from two outbreaks, Democratic Republic of the Congo. Emerging Infectious Diseases2011;17(5):778-84. ">Bertherat 2011</a> (2005 outbreak)<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50% (1 to 99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> (<i>pla</i> and <i>caf1</i>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> (<i>caf1</i>)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95% (89 to 99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93% (84 to 98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> (<i>pla</i>)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72% (63 to 80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>93% (77 to 99)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0013" title="RiehmJM , RahalisonL , ScholzHC , ThomaB , PfefferM , RazanakotoLM , et al. Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Molecular and Cellular Probes2011;25(1):8-12. ">Riehm 2011</a> (<i>Ymt</i>)<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92% (84 to 97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87% (76 to 94)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus paired serology</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0012" title="RichardV , RiehmJM , HerindrainyP , SoanandrasanaR , RatsitoharinaM , RakotomananaF , et al. Pneumonic plague outbreak, northern Madagascar, 2011. Emerging infectious diseases2015;21(1):8-15. ">Richard 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>IPM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pneumonic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100% (16 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr> <th align="" class="headercell" colspan="9" rowspan="1" scope="col" valign="top"> <p><b>F1RDT versus culture or paired serology</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013459-bbs2-0004" title="PetersenJ . Status of plague diagnostics for vaccine evaluation. www.who.int/blueprint/what/norms-standards/Plague_vaccines_workshop-23-april-2018/en/ (accessed 28 August 2019). ">Petersen 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bubonic, pneumonic, septicaemic, cutaneous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91% (84 to 95)<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88% (83 to 93)<sup>d</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>Abbreviations: CI: confidence interval; F1RDT: F1 antigen rapid diagnostic test; FN: false negative; FP: false positive; IPM: Institut Pasteur of Madagascar; NDD: no disaggregated data; NH: New Horizons; NR: not reported; PCR: polymerase chain reaction; TN: true negative; TP: true positive. </p> <p>Note: we presented findings for positivity of F1RDT interpreted from 1+.<br/><sup>a</sup>The authors determined positive disease status when either RDT performed onsite or at the central laboratory was positive. Five cases had a positive RDT when performed onsite but negative when repeated at the central laboratory; and two cases had a negative RDT when performed onsite but positive when repeated at the central laboratory.<br/><sup>b</sup>There were no participants with both PCR and F1RDT findings reported from the 2006 outbreak. The gene tested by PCR during the 2005 outbreak was not specified.<br/><sup>c</sup>Three genes (<i>caf1</i> , <i>pla</i> , <i>Ymt</i>) were tested for the same group of participants. Therefore, findings for these three rows corresponded to the same cohort of participants.<br/><sup>d</sup>There was limited published available data for this study. Raw data on TP, TN, FP, and FN were not reported. The sensitivity and specificity estimates are those reported by the study authors. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Disaggregated findings of F1RDT for diagnosing plague</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/full#CD013459-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013459-tbl-0007"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 F1RDT versus culture for all forms of plague, primary analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3696</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">2 F1RDT versus culture for all forms of plague, sensitivity analysis 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5038</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">3 F1RDT versus culture for all forms of plague, sensitivity analysis 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3629</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013459.pub2/references#CD013459-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013459.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013459-note-0016">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013459-note-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013459-note-0015">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013459-note-0013">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD013459-note-0012">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD013459-note-0010">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013459-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013459-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013459\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013459\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013459\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013459\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013459\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013459.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013459.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013459.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013459.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013459.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726343469"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013459.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726343473"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013459.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e91571de49368',t:'MTc0MDcyNjM0My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 